Chorioamnionitis is inflammation of the fetal membranes (chorion and amnion), in most cases provoked by ascending polymicrobial invasion of the amniotic cavity from the lower genital tract. It is simultaneously a clinical syndrome of the laboring patient, a histopathological lesion of the placenta, and a fetal exposure, and these three faces do not overlap neatly. Because the same neutrophilic lesion can be produced by microorganisms or, in the absence of demonstrable organisms, by endogenous danger signals, the entity is best modeled as a shared inflammatory final common pathway rather than as a single infection. It is a leading antecedent of preterm labor, preterm prelabor rupture of membranes, early-onset neonatal sepsis, and the fetal inflammatory response syndrome that links intrauterine inflammation to periventricular leukomalacia, cerebral palsy, and chronic lung disease of prematurity.
Ask a research question about Chorioamnionitis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Chorioamnionitis
creation_date: "2026-08-04T00:00:00Z"
category: Infectious Disease
disease_term:
preferred_term: chorioamnionitis
term:
id: MONDO:0000409
label: chorioamnionitis
description: >
Chorioamnionitis is inflammation of the fetal membranes (chorion and amnion),
in most cases provoked by ascending polymicrobial invasion of the amniotic
cavity from the lower genital tract. It is simultaneously a clinical syndrome
of the laboring patient, a histopathological lesion of the placenta, and a
fetal exposure, and these three faces do not overlap neatly. Because the same
neutrophilic lesion can be produced by microorganisms or, in the absence of
demonstrable organisms, by endogenous danger signals, the entity is best
modeled as a shared inflammatory final common pathway rather than as a single
infection. It is a leading antecedent of preterm labor, preterm prelabor
rupture of membranes, early-onset neonatal sepsis, and the fetal inflammatory
response syndrome that links intrauterine inflammation to periventricular
leukomalacia, cerebral palsy, and chronic lung disease of prematurity.
synonyms:
- intraamniotic infection
- intra-amniotic infection
- intrauterine inflammation or infection or both
- Triple I
- amnionitis
- fetal membrane inflammation
parents:
- Bacterial infectious disease
- Inflammatory disease
- Disorder of extraembryonic membrane
- Obstetric infection
has_subtypes:
- name: Clinical
display_name: Clinical chorioamnionitis (intraamniotic infection, Triple I)
description: >
The intrapartum clinical syndrome, suspected when maternal fever is
accompanied by additional maternal or fetal signs of inflammation. The 2015
NICHD workshop argued this label had been stretched across a heterogeneous
set of conditions and proposed the descriptive replacement term Triple I,
stressing that isolated maternal fever is not the same thing as
chorioamnionitis.
evidence:
- reference: PMID:26855098
reference_title: "Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
It is particularly important to recognize that an isolated maternal fever
is not synonymous with chorioamnionitis.
explanation: >-
NICHD expert-panel workshop statement establishing that the clinical
subtype is a defined syndrome rather than fever alone. Evidence source is
OTHER because this is a consensus workshop summary rather than primary
data.
- reference: PMID:26855098
reference_title: "Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The panel noted that the term chorioamnionitis has been used to label a
heterogeneous array of conditions characterized by infection and
inflammation or both with a consequent great variation in clinical
practice for mothers and their newborns.
explanation: >-
Documents the heterogeneity that motivates splitting the clinical syndrome
from the histologic lesion in this entry.
- name: Histologic Acute
display_name: Acute histologic chorioamnionitis
description: >
The placental-pathology diagnosis: diffuse neutrophilic infiltration of the
chorioamniotic membranes, staged and graded by the Amsterdam criteria. It is
far more common than the clinical syndrome and its frequency rises steeply as
gestational age at delivery falls. It is subdivided into the maternal
inflammatory response (maternal neutrophils in chorion and amnion) and the
fetal inflammatory response (funisitis and chorionic vasculitis).
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Acute inflammatory lesions of the placenta consist of diffuse infiltration
of neutrophils at different sites in the organ.
explanation: >-
Defines the histologic subtype as a neutrophil-infiltration lesion of the
placenta.
- reference: PMID:27223167
reference_title: "Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The terminology and microscopic descriptions for maternal vascular
malperfusion, fetal vascular malperfusion, delayed villous maturation,
patterns of ascending intrauterine infection, and villitis of unknown
etiology were agreed upon.
explanation: >-
Amsterdam Placental Workshop Group consensus supplying the standardized
diagnostic criteria under which this subtype is reported.
- name: Chronic
display_name: Chronic chorioamnionitis
description: >
A mechanistically distinct lesion sharing the name: lymphohistiocytic rather
than neutrophilic, characterized by maternal CD8+ T cell infiltration of the
chorioamniotic membranes and attributed to maternal anti-fetal rejection
rather than to infection. It is the most common placental lesion of late
spontaneous preterm birth. It is curated here so that the acute infectious
entity is not silently conflated with it.
evidence:
- reference: PMID:26428503
reference_title: "Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Chronic chorioamnionitis is the most common lesion in late spontaneous
preterm birth and is characterized by the infiltration of maternal CD8+ T
cells into the chorioamniotic membranes.
explanation: >-
Establishes the chronic subtype as a distinct, T-cell-mediated lesion of
the same anatomical site.
infectious_agent:
- name: Ureaplasma urealyticum
infectious_agent_term:
preferred_term: Ureaplasma urealyticum
term:
id: NCBITaxon:2130
label: Ureaplasma urealyticum
description: >
Genital mycoplasma that is the most frequently recovered organism from the
amniotic cavity in intraamniotic infection. Despite a reputation as a
low-virulence commensal, it provokes a substantial host inflammatory
response when it is the sole isolate.
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The most common microorganisms are Ureaplasma species, and polymicrobial
infections occur in 70% of cases.
explanation: >-
Identifies Ureaplasma as the predominant isolate and documents the
polymicrobial character of the infection.
- reference: PMID:9822511
reference_title: "Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The prevalence of a positive amniotic fluid culture in which the only
microbial isolate was U urealyticum was 21% (25/120) and that of positive
cultures with other or mixed microorganisms was 9% (11/120).
explanation: >-
Human amniocentesis series in preterm prelabor rupture of membranes
showing U. urealyticum as the single most frequently isolated organism,
more common than all other organisms combined.
- name: Ureaplasma parvum
infectious_agent_term:
preferred_term: Ureaplasma parvum
term:
id: NCBITaxon:134821
label: Ureaplasma parvum
description: >
The other genital Ureaplasma species recovered from amniotic fluid, commonly
detected by molecular rather than culture methods.
- name: Mycoplasma hominis
infectious_agent_term:
preferred_term: Mycoplasma hominis
term:
id: NCBITaxon:2098
label: Metamycoplasma hominis
description: >
Frequent co-isolate with Ureaplasma species; concurrent detection is
associated with true intra-amniotic infection rather than sterile
inflammation. The NCBI Taxonomy label is the reassigned genus name
Metamycoplasma hominis; the clinically used name is retained in
preferred_term.
evidence:
- reference: PMID:34238107
reference_title: "Intra-amniotic infection and sterile intra-amniotic inflammation in women with preterm labor with intact membranes are associated with a higher rate of Ureaplasma species DNA presence in the cervical fluid."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Concurrent presence of Ureaplasma spp. and Mycoplasma hominis DNA was
higher in women with intra-amniotic infection (42% (5/12)) than women with
sterile intra-amniotic inflammation (7% (2/29))
explanation: >-
Human cohort of preterm labor showing co-detection of M. hominis marks the
infectious rather than the sterile form.
- name: Streptococcus agalactiae
infectious_agent_term:
preferred_term: Streptococcus agalactiae
term:
id: NCBITaxon:1311
label: Streptococcus agalactiae
description: >
Group B Streptococcus. A less frequent cause of intraamniotic infection than
the genital mycoplasmas but a disproportionately important one, because it is
a leading cause of early-onset neonatal sepsis and is the target of
intrapartum antibiotic prophylaxis.
- name: Escherichia coli
infectious_agent_term:
preferred_term: Escherichia coli
term:
id: NCBITaxon:562
label: Escherichia coli
description: >
Gram-negative organism whose lipopolysaccharide is the canonical TLR4 ligand
in this pathway; a major cause of early-onset sepsis in preterm neonates.
- name: Fusobacterium nucleatum
infectious_agent_term:
preferred_term: Fusobacterium nucleatum
term:
id: NCBITaxon:851
label: Fusobacterium nucleatum
description: >
Anaerobe of oral origin, notable because it reaches the amniotic cavity
hematogenously rather than by ascent, providing the mechanistic link between
periodontal disease and intrauterine infection.
pathophysiology:
- name: Vaginal Dysbiosis and Cervical Barrier Breach
biological_scale: ORGANISM
description: >
Loss of Lactobacillus dominance and overgrowth of anaerobes associated with
bacterial vaginosis lowers the chemical and ecological barrier at the cervix,
permitting organisms of the lower genital tract to reach the choriodecidual
interface. Instrumentation of the cervix during labor, prolonged rupture of
membranes, and cerclage act on the same step by breaching the mechanical
barrier.
role: trigger
downstream:
- target: Ascending Microbial Invasion of the Amniotic Cavity
causal_link_type: DIRECT
description: >
Breach of the cervical barrier permits ascent of lower genital tract
organisms into the choriodecidual space and amniotic cavity.
- name: Ascending Microbial Invasion of the Amniotic Cavity
biological_scale: TISSUE
description: >
Organisms colonize the choriodecidual space and then cross into the amniotic
fluid. The infection is characteristically polymicrobial and dominated by
genital mycoplasmas, which is why culture-based diagnosis systematically
underestimates it. Invasion is the step that distinguishes true
intraamniotic infection from sterile intra-amniotic inflammation.
locations:
- preferred_term: amniotic fluid
term:
id: UBERON:0000173
label: amniotic fluid
- preferred_term: fetal membrane
term:
id: UBERON:0005630
label: fetal membrane
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The most common microorganisms are Ureaplasma species, and polymicrobial
infections occur in 70% of cases.
explanation: >-
Characterizes the microbiology of the invading flora at this node.
- reference: PMID:28742677
reference_title: "Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Intraamniotic infection, also known as chorioamnionitis, is an infection
with resultant inflammation of any combination of the amniotic fluid,
placenta, fetus, fetal membranes, or decidua.
explanation: >-
Professional-society definition establishing the anatomical compartments
invaded at this node.
- reference: PMID:34238107
reference_title: "Intra-amniotic infection and sterile intra-amniotic inflammation in women with preterm labor with intact membranes are associated with a higher rate of Ureaplasma species DNA presence in the cervical fluid."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Intra-amniotic infection and sterile inflammation were identified in 14%
(16/115) and 25% (29/115) of the women, respectively.
explanation: >-
Quantifies, in a human preterm-labor cohort, how often microbial invasion
is actually demonstrable versus inflammation without organisms, supporting
the split between this node and the sterile arm.
downstream:
- target: Pattern Recognition Receptor Activation at the Maternal-Fetal Interface
causal_link_type: DIRECT
description: >
Microbial products including lipopolysaccharide and mycoplasmal
lipoproteins engage innate pattern recognition receptors on membrane and
decidual cells.
- name: Alarmin Release and Sterile Intra-amniotic Inflammation
biological_scale: MOLECULAR
description: >
Endogenous danger signals released by cellular stress or cell death in the
membranes engage the same innate receptors as microbial products, producing
an inflammatory lesion indistinguishable from the infectious one in the
absence of demonstrable organisms. This arm is not a curiosity: in cohorts of
preterm labor it is detected more often than microbial invasion itself, and
it is the reason chorioamnionitis is modeled here as an inflammatory rather
than a purely infectious final common pathway.
role: trigger
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Danger signals that are released during the course of cellular stress or
cell death can also induce the release of neutrophil chemokines.
explanation: >-
Establishes that endogenous alarmins drive the same chemokine output as
microbial invasion.
- reference: PMID:34238107
reference_title: "Intra-amniotic infection and sterile intra-amniotic inflammation in women with preterm labor with intact membranes are associated with a higher rate of Ureaplasma species DNA presence in the cervical fluid."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Intra-amniotic infection and sterile inflammation were identified in 14%
(16/115) and 25% (29/115) of the women, respectively.
explanation: >-
Human cohort in which sterile intra-amniotic inflammation was nearly twice
as frequent as demonstrable intra-amniotic infection.
downstream:
- target: Pattern Recognition Receptor Activation at the Maternal-Fetal Interface
causal_link_type: DIRECT
description: >
Alarmins converge on the same innate receptor machinery engaged by
microbial ligands.
- name: Pattern Recognition Receptor Activation at the Maternal-Fetal Interface
biological_scale: MOLECULAR
description: >
Toll-like receptors on amnion epithelium, chorionic trophoblast, decidual
stromal cells, and resident macrophages read both microbial products and
endogenous danger signals. TLR2 and TLR4 expression in the chorioamniotic
membranes is increased in the presence of histologic chorioamnionitis. This
node is the convergence point that makes the infectious and sterile arms
mechanistically indistinguishable downstream.
biological_processes:
- preferred_term: toll-like receptor signaling pathway
term:
id: GO:0002224
label: toll-like receptor signaling pathway
modifier: INCREASED
- preferred_term: response to lipopolysaccharide
term:
id: GO:0032496
label: response to lipopolysaccharide
modifier: INCREASED
cell_types:
- preferred_term: chorionic trophoblast cell
term:
id: CL:0011101
label: chorionic trophoblast cell
- preferred_term: decidual cell
term:
id: CL:2000002
label: decidual cell
evidence:
- reference: PMID:15507964
reference_title: "Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Spontaneous labor at term and preterm delivery with histologic
chorioamnionitis, regardless of the membrane status (intact or ruptured),
are associated with an increased expression of Toll-like receptor-2 and -4
in the chorioamniotic membranes.
explanation: >-
Human membrane tissue study demonstrating upregulated TLR2 and TLR4 in the
chorioamniotic membranes of cases with histologic chorioamnionitis,
directly supporting this node.
downstream:
- target: Proinflammatory Cytokine and Chemokine Production
causal_link_type: DIRECT
description: >
Toll-like receptor engagement is signal 1, the priming step: it drives
NF-kB-dependent transcription of the inflammatory cytokine and chemokine
program, including inactive pro-IL-1 beta.
- target: NLRP3 Inflammasome Activation and Pyroptosis
causal_link_type: DIRECT
description: >
Priming also licenses the cell to assemble the NLRP3 inflammasome, which
when triggered constitutes signal 2 and converts the primed pro-IL-1 beta
into its mature form.
- name: NLRP3 Inflammasome Activation and Pyroptosis
biological_scale: CELLULAR
description: >
Assembly of the NLRP3 inflammasome activates caspase-1, which both matures
pro-IL-1 beta and IL-18 and cleaves gasdermin D. Gasdermin D pores drive
pyroptosis of amnion and decidual cells, releasing further alarmins and
closing a self-amplifying loop. This is the step that converts a local
signal into a syndrome: transcription alone yields inactive pro-IL-1 beta,
so without this node the mechanism by which the cytokine becomes
biologically active is unexplained. The node is engaged in both the
infectious and the sterile arm, which is part of why the two are
indistinguishable downstream.
biological_processes:
- preferred_term: interleukin-1 beta production
term:
id: GO:0032611
label: interleukin-1 beta production
modifier: INCREASED
cellular_components:
- preferred_term: NLRP3 inflammasome complex
term:
id: GO:0072559
label: NLRP3 inflammasome complex
evidence:
- reference: PMID:31461796
reference_title: "Gasdermin D: Evidence of pyroptosis in spontaneous preterm labor with sterile intra-amniotic inflammation or intra-amniotic infection."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Gasdermin D was detected in the amniotic fluid and chorioamniotic
membranes from women who underwent spontaneous preterm labor/birth with
either sterile intra-amniotic inflammation or intra-amniotic infection,
but was rarely detected in those without intra-amniotic inflammation.
explanation: >-
Human amniotic fluid and membrane study showing the pyroptosis effector
gasdermin D is present specifically when intra-amniotic inflammation is
present, and in both the sterile and the infectious arm.
- reference: PMID:30596885
reference_title: "Inhibition of the NLRP3 inflammasome can prevent sterile intra-amniotic inflammation, preterm labor/birth, and adverse neonatal outcomes†."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Herein, we investigated whether the alarmin S100B could induce sterile
intra-amniotic inflammation by activating the NLRP3 inflammasome, and
whether the inhibition of this pathway could prevent preterm labor/birth
and adverse neonatal outcomes.
explanation: >-
Murine intra-amniotic model testing the NLRP3 inflammasome as the
mechanistic link from alarmin to preterm birth. Recorded as
MODEL_ORGANISM because the interventional causal step is demonstrated in
mice, not in humans.
downstream:
- target: Proinflammatory Cytokine and Chemokine Production
causal_link_type: DIRECT
description: >
Caspase-1 maturation of IL-1 beta supplies the biologically active
cytokine that drives the downstream chemotactic and uterotonic arms.
- target: Alarmin Release and Sterile Intra-amniotic Inflammation
causal_link_type: DIRECT
description: >
Pyroptotic lysis of amnion and decidual cells releases further
intracellular alarmins, feeding back onto the sterile trigger node.
- name: Proinflammatory Cytokine and Chemokine Production
biological_scale: CELLULAR
description: >
Innate receptor signaling drives production of IL-1 beta, IL-6, TNF, and the
neutrophil chemokine IL-8 within the membranes and decidua. Amniotic fluid
IL-6 rises accordingly and is the operational marker of intra-amniotic
inflammation. This node is the amplification step that converts a local
signal into a syndrome, and it is the branch point from which the
chemotactic, uterotonic, and matrix-degrading arms diverge.
biological_processes:
- preferred_term: cytokine production involved in inflammatory response
term:
id: GO:0002534
label: cytokine production involved in inflammatory response
modifier: INCREASED
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
chemokines (such as interleukin-8 and granulocyte chemotactic protein)
establish a gradient that favors the migration of neutrophils from the
maternal or fetal circulation into the chorioamniotic membranes or
umbilical cord, respectively
explanation: >-
Identifies the chemokine output of this node and the gradient it
establishes.
downstream:
- target: Neutrophil Chemotaxis into the Chorioamniotic Membranes
causal_link_type: DIRECT
description: >
IL-8 and related chemokines establish the gradient that recruits
neutrophils.
- target: Prostaglandin Synthesis and Myometrial Activation
causal_link_type: DIRECT
description: >
IL-1 beta and TNF upregulate prostaglandin synthesis and myometrial
activation.
hypothesis_groups:
- preterm_uterotonic_activation
- target: MMP-Mediated Chorioamniotic Matrix Degradation
causal_link_type: DIRECT
description: >
Cytokine signaling induces matrix metalloproteinases that degrade the
membrane collagen scaffold.
- target: Reduced Myometrial Contractility at Term
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >
At term, the same inflammatory mediator load is associated with decreased
uterine activity and dysfunctional labor rather than with effective
contraction. The intermediates that determine the direction of this effect
are not established.
hypothesis_groups:
- term_myometrial_suppression
- name: Neutrophil Chemotaxis into the Chorioamniotic Membranes
biological_scale: CELLULAR
description: >
Neutrophils migrate along the chemokine gradient toward the amniotic cavity.
Crucially the traffic has two separate sources: maternal neutrophils enter
from decidual vessels through chorion into amnion, while fetal neutrophils
later cross chorionic plate and umbilical vessels. This directional
two-source migration is what the histologic lesion actually consists of.
biological_processes:
- preferred_term: neutrophil chemotaxis
term:
id: GO:0030593
label: neutrophil chemotaxis
modifier: INCREASED
cell_types:
- preferred_term: neutrophil
term:
id: CL:0000775
label: neutrophil
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
chemokines (such as interleukin-8 and granulocyte chemotactic protein)
establish a gradient that favors the migration of neutrophils from the
maternal or fetal circulation into the chorioamniotic membranes or
umbilical cord, respectively
explanation: >-
Describes the two-source neutrophil migration that constitutes this node.
downstream:
- target: Maternal Inflammatory Response and Acute Chorioamnionitis
causal_link_type: DIRECT
description: >
Maternal neutrophil infiltration of chorion and amnion produces the
maternal inflammatory response lesion.
- target: Fetal Inflammatory Response with Funisitis and Chorionic Vasculitis
causal_link_type: DIRECT
description: >
Fetal neutrophil migration into umbilical and chorionic plate vessels
produces the fetal inflammatory response lesion.
- name: Maternal Inflammatory Response and Acute Chorioamnionitis
biological_scale: TISSUE
description: >
Diffuse maternal neutrophil infiltration of the chorioamniotic membranes.
This is the maternal arm of the histologic lesion and the one that gives the
disease its name. Its frequency is steeply gestational-age dependent, which
is the single most important epidemiological fact about the lesion.
locations:
- preferred_term: fetal membrane
term:
id: UBERON:0005630
label: fetal membrane
- preferred_term: amnion
term:
id: UBERON:0000305
label: amnion
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
While acute chorioamnionitis is evidence of a maternal host response,
funisitis and chorionic vasculitis represent fetal inflammatory responses.
explanation: >-
Establishes that acute chorioamnionitis proper is the maternal arm of the
response, separating it from the fetal arm modeled in the adjacent node.
- name: Fetal Inflammatory Response with Funisitis and Chorionic Vasculitis
biological_scale: TISSUE
description: >
Fetal neutrophils migrate into the walls of the umbilical vessels and
chorionic plate vessels. Unlike the maternal lesion this represents the
fetus's own response, and it is the histologic hallmark of systemic fetal
inflammation. It predicts neonatal outcome considerably better than the
maternal lesion does.
locations:
- preferred_term: umbilical cord
term:
id: UBERON:0002331
label: umbilical cord
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Funisitis and chorionic vasculitis are the hallmarks of the fetal
inflammatory response syndrome, a condition characterized by an elevation
in the fetal plasma concentration of interleukin-6
explanation: >-
Links this histologic node to the systemic fetal syndrome it marks.
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Pathologic evidence of a systemic fetal inflammatory response indicates
the presence of funisitis or chorionic vasculitis.
explanation: >-
Confirms funisitis and chorionic vasculitis as the pathological criteria
for the fetal systemic response.
downstream:
- target: Fetal Inflammatory Response Syndrome
causal_link_type: DIRECT
description: >
The local fetal vascular lesion is the histologic counterpart of the
systemic fetal inflammatory syndrome.
- name: Prostaglandin Synthesis and Myometrial Activation
biological_scale: MOLECULAR
description: >
Inflammatory cytokines upregulate prostaglandin synthesis while the enzyme
that normally degrades prostaglandins is downregulated, and gap-junction and
oxytocin-receptor expression rise. The quiescent myometrium is converted into
a contractile syncytium, driving labor at a gestational age at which it
should not be occurring.
biological_processes:
- preferred_term: prostaglandin biosynthetic process
term:
id: GO:0001516
label: prostaglandin biosynthetic process
modifier: INCREASED
notes: >-
GO:0007567 parturition was deliberately not bound here: it is a
whole-organism process and this node is tagged MOLECULAR. The
myometrial-activation semantics are carried by the node name, the
description, and the downstream edge to Preterm Labor and Birth.
downstream:
- target: Preterm Labor and Birth
causal_link_type: DIRECT
description: >
Prostaglandin-driven myometrial activation produces preterm contractions
and delivery.
hypothesis_groups:
- preterm_uterotonic_activation
- name: MMP-Mediated Chorioamniotic Matrix Degradation
biological_scale: MOLECULAR
description: >
Neutrophil-derived matrix metalloproteinase-8 (neutrophil collagenase) and
MMP-9, together with elastase, degrade the collagen scaffold of the
amniochorion while tissue inhibitors of metalloproteinases fall. Amniotic
fluid MMP-8 is correspondingly a sensitive marker of intra-amniotic
infection.
evidence:
- reference: PMID:11717662
reference_title: "Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our results indicate that matrix metalloproteinase-8 is highly correlated
with intra-amniotic infection
explanation: >-
Human case-control study of amniotic fluid establishing MMP-8 as the
protease signature of this node.
downstream:
- target: Membrane Weakening and Preterm Prelabor Rupture of Membranes
causal_link_type: DIRECT
description: >
Collagen degradation reduces the tensile strength of the fetal membranes.
- name: Membrane Weakening and Preterm Prelabor Rupture of Membranes
biological_scale: TISSUE
description: >
Loss of tensile strength in the amniochorion leads to rupture before the
onset of labor. This closes a vicious circle: rupture removes the remaining
physical barrier and permits further ascending colonization, so preterm
prelabor rupture of membranes is both a consequence and a cause of
intra-amniotic infection.
locations:
- preferred_term: fetal membrane
term:
id: UBERON:0005630
label: fetal membrane
downstream:
- target: Preterm Labor and Birth
causal_link_type: DIRECT
description: >
Preterm prelabor rupture of membranes precipitates preterm delivery.
- target: Ascending Microbial Invasion of the Amniotic Cavity
causal_link_type: DIRECT
description: >
Rupture removes the barrier to further ascending colonization, feeding
back onto the invasion node.
- name: Preterm Labor and Birth
biological_scale: ORGANISM
description: >
Delivery before 37 completed weeks. Intrauterine infection and inflammation
account for a substantial share of spontaneous preterm births, and the
proportion rises as gestational age at delivery falls.
- name: Reduced Myometrial Contractility at Term
biological_scale: TISSUE
description: >
At term the inflammatory milieu is associated with the opposite uterine
behavior from the preterm case: decreased uterine activity, failure to
progress in labor, higher cesarean rates, and postpartum uterine atony with
hemorrhage. This is curated as a distinct node rather than as a
sign-reversing edge on the uterotonic arm, because the mechanisms are
separated by gestational age and receptor context rather than contradicting
one another.
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Clinical chorioamnionitis is associated with decreased uterine activity,
failure to progress in labor, and postpartum hemorrhage
explanation: >-
Documents the term-gestation myometrial phenotype that this node
represents.
- reference: PMID:28742677
reference_title: "Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Maternal morbidity from intraamniotic infection also can be significant,
and may include dysfunctional labor requiring increased intervention,
postpartum uterine atony with hemorrhage, endometritis, peritonitis,
sepsis, adult respiratory distress syndrome and, rarely, death.
explanation: >-
Professional-society statement independently documenting dysfunctional
labor and postpartum atony as consequences of this node.
- name: Fetal Inflammatory Response Syndrome
biological_scale: ORGANISM
description: >
A systemic inflammatory response mounted by the fetus itself, defined
operationally by elevated fetal or cord plasma IL-6 and pathologically by
funisitis or chorionic vasculitis. It is the fetal counterpart of the adult
systemic inflammatory response syndrome, it is multi-organ, and it is the
mechanistic bridge between an obstetric infection and lifelong
neurodevelopmental and respiratory disability.
evidence:
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
FIRS can be diagnosed by an increased concentration of umbilical cord
plasma or serum acute phase reactants such as C-reactive protein or
cytokines (e.g., interleukin-6).
explanation: >-
Defines the biochemical criterion for this node.
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Neonates born with FIRS have a higher rate of complications, such as
early-onset neonatal sepsis, intraventricular hemorrhage, periventricular
leukomalacia, and death, than those born without FIRS.
explanation: >-
Establishes the downstream neonatal consequences modeled by the edges from
this node.
downstream:
- target: Microglial Activation and Preterm White Matter Injury
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
description: >
Circulating fetal cytokines activate microglia and injure the vulnerable
pre-oligodendrocyte population of the preterm white matter.
intermediate_mechanisms:
- Systemic fetal cytokinemia
- Blood-brain barrier permeability change
- target: Fetal Pulmonary Inflammation and Arrested Alveolarization
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
description: >
Aspirated infected amniotic fluid and circulating cytokines inflame the
fetal lung and disturb alveolar and microvascular development.
intermediate_mechanisms:
- Fetal pneumonitis
- target: Early-Onset Neonatal Sepsis
causal_link_type: DIRECT
description: >
Fetal systemic inflammation and microbial exposure predispose to
early-onset invasive neonatal infection.
- name: Microglial Activation and Preterm White Matter Injury
biological_scale: CELLULAR
description: >
Fetal systemic inflammation activates microglia; pre-oligodendrocytes, which
are exquisitely vulnerable in the 23 to 32 week window, die by oxidative and
excitotoxic injury and myelination fails. This is the cellular substrate of
periventricular leukomalacia and of the cerebral palsy that follows.
biological_processes:
- preferred_term: inflammatory response
term:
id: GO:0006954
label: inflammatory response
modifier: INCREASED
cell_types:
- preferred_term: microglial cell
term:
id: CL:0000129
label: microglial cell
evidence:
- reference: PMID:10989405
reference_title: "Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Using a random effects model, clinical chorioamnionitis was significantly
associated with both cerebral palsy (RR, 1.9; 95% CI, 1.4-2.5) and cPVL
(RR, 3.0; 95% CI, 2.2-4.0) in preterm infants.
explanation: >-
Meta-analysis quantifying the association of chorioamnionitis with cystic
periventricular leukomalacia and cerebral palsy, the clinical readouts of
this node.
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Survivors are at risk for long-term sequelae that may include
bronchopulmonary dysplasia, neurodevelopmental disorders, such as cerebral
palsy, retinopathy of prematurity, and sensorineuronal hearing loss.
explanation: >-
Links fetal systemic inflammation to the long-term neurodevelopmental
outcomes this node produces.
- name: Fetal Pulmonary Inflammation and Arrested Alveolarization
biological_scale: TISSUE
description: >
Fetal lung exposure to infected amniotic fluid and inflammatory cytokines
produces pneumonitis and a dissociation between functional and structural
maturation: surfactant production is induced while alveolarization and
microvascular development are suppressed, the arrested-development phenotype
underlying bronchopulmonary dysplasia. The strength of this association in
humans is genuinely contested, and the entry records that dispute rather than
smoothing it over.
evidence:
- reference: PMID:21697236
reference_title: "Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The pooled unadjusted OR showed that CA was significantly associated with
BPD (OR 1.89, 95% CI 1.56 to 2.3).
explanation: >-
Meta-analysis of 59 human studies quantifying the association with
bronchopulmonary dysplasia.
- reference: PMID:21697236
reference_title: "Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Despite a large body of evidence, CA cannot be definitively considered a
risk factor for BPD.
explanation: >-
The same meta-analysis found strong evidence of publication bias and
declined to call the association definitive. Recorded as PARTIAL so the
entry does not overstate this edge.
- name: Early-Onset Neonatal Sepsis
biological_scale: ORGANISM
description: >
Invasive neonatal infection within the first 72 hours of life. Notably, the
rate of culture-confirmed neonatal bacteremia after clinical chorioamnionitis
is low in absolute terms even though the relative risk is high, which is the
tension underlying the modern shift from treating every exposed newborn to
risk-stratified evaluation.
evidence:
- reference: PMID:33957655
reference_title: "Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Both histologic and clinical chorioamnionitis were associated with early-
and late-onset sepsis in neonates.
explanation: >-
Systematic review and meta-analysis of 103 human studies supporting this
node for both the histologic and clinical subtypes.
- reference: PMID:28742677
reference_title: "Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Intraamniotic infection can be associated with acute neonatal morbidity,
including neonatal pneumonia, meningitis, sepsis, and death.
explanation: >-
Professional-society statement of the acute neonatal infectious outcomes
at this node.
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The fetal attack rate is low, and the rate of positive neonatal blood
cultures ranges between 0.2% and 4%.
explanation: >-
Qualifies the absolute risk at this node, which is the basis for
risk-stratified rather than universal neonatal antibiotic treatment.
- name: Chronic Chorioamnionitis and Maternal Anti-Fetal Rejection
biological_scale: TISSUE
description: >
A separate, non-neutrophilic arm that shares the anatomical site and the
name. Maternal CD8+ T cells infiltrate the chorioamniotic membranes and can
induce trophoblast apoptosis, in a process framed as rejection of the fetal
semiallograft rather than as infection. It is the most common placental
lesion in late spontaneous preterm birth.
cell_types:
- preferred_term: CD8-positive, alpha-beta T cell
term:
id: CL:0000625
label: CD8-positive, alpha-beta T cell
locations:
- preferred_term: fetal membrane
term:
id: UBERON:0005630
label: fetal membrane
evidence:
- reference: PMID:26428503
reference_title: "Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
These cytotoxic T cells can induce trophoblast apoptosis and damage the
fetal membranes.
explanation: >-
Describes the effector mechanism of the chronic, immune-mediated arm.
downstream:
- target: Preterm Labor and Birth
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >
Chronic chorioamnionitis is the most common placental lesion of late
spontaneous preterm birth, though the intermediate steps from T-cell
infiltration to the onset of labor are not established.
mechanistic_hypotheses:
- hypothesis_group_id: preterm_uterotonic_activation
hypothesis_label: Inflammation-driven uterotonic activation causing preterm labor
status: CANONICAL
description: >
The canonical model: inflammatory cytokines raise prostaglandin synthesis and
myometrial gap-junction and oxytocin-receptor expression, converting the
quiescent preterm uterus into a contractile organ and precipitating preterm
labor.
- hypothesis_group_id: term_myometrial_suppression
hypothesis_label: Inflammation-associated suppression of myometrial contractility at term
status: EMERGING
description: >
The apparently contradictory observation that at term the same inflammatory
setting is associated with decreased uterine activity, dysfunctional labor,
and postpartum atony rather than with effective contraction. Curated as a
separate hypothesis group rather than as a sign-reversal on the preterm edge,
because the two are separated by gestational age and receptor context; the
determinants of the direction of effect are not established.
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Clinical chorioamnionitis is associated with decreased uterine activity,
failure to progress in labor, and postpartum hemorrhage
explanation: >-
Documents the term-gestation direction of effect that motivates a separate
hypothesis group.
phenotypes:
- category: Clinical
name: Maternal Fever
description: >
Intrapartum maternal fever is the entry criterion for the clinical syndrome,
but is explicitly not sufficient for the diagnosis on its own. The HPO term
for maternal fever in pregnancy (HP:0030244) sits under Past medical history
rather than under Phenotypic abnormality and is therefore outside the
curatable phenotype hierarchy, so the generic Fever term is bound here
instead.
phenotype_term:
preferred_term: Maternal intrapartum fever
term:
id: HP:0001945
label: Fever
frequency: OBLIGATE
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The condition is suspected when intrapartum fever is associated with two
other maternal and fetal signs of local or systemic inflammation
explanation: >-
Establishes fever as the obligate anchor sign of the clinical syndrome,
requiring additional signs for diagnosis.
- reference: PMID:26855098
reference_title: "Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
It is particularly important to recognize that an isolated maternal fever
is not synonymous with chorioamnionitis.
explanation: >-
Qualifies the frequency assignment: fever is obligate for the diagnosis
but is not by itself diagnostic.
subtype: Clinical
- category: Clinical
name: Maternal Tachycardia
description: >
Maternal heart rate above 100 beats per minute, one of the supporting signs
required alongside fever for the clinical diagnosis.
phenotype_term:
preferred_term: Maternal tachycardia
term:
id: HP:0001649
label: Tachycardia
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The condition is suspected when intrapartum fever is associated with two
other maternal and fetal signs of local or systemic inflammation (eg,
maternal tachycardia, uterine tenderness, maternal leukocytosis,
malodorous vaginal discharge or amniotic fluid, and fetal tachycardia).
explanation: >-
Lists maternal tachycardia among the defining supporting signs.
subtype: Clinical
- category: Laboratory
name: Maternal Leukocytosis
description: >
Elevated maternal white blood cell count, one of the supporting criteria for
the clinical diagnosis. Interpretation is complicated by the physiological
leukocytosis of labor and by corticosteroid administration.
phenotype_term:
preferred_term: Maternal leukocytosis
term:
id: HP:0001974
label: Increased total leukocyte count
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The condition is suspected when intrapartum fever is associated with two
other maternal and fetal signs of local or systemic inflammation (eg,
maternal tachycardia, uterine tenderness, maternal leukocytosis,
malodorous vaginal discharge or amniotic fluid, and fetal tachycardia).
explanation: >-
Lists maternal leukocytosis among the defining supporting signs.
subtype: Clinical
- category: Clinical
name: Premature Rupture of Membranes
description: >
Rupture of the fetal membranes before the onset of labor. Both a risk factor
for and a consequence of intra-amniotic infection, which is why it appears in
the pathograph as a feedback edge rather than as a simple endpoint.
phenotype_term:
preferred_term: Preterm prelabor rupture of membranes
term:
id: HP:0001788
label: Premature rupture of membranes
- category: Clinical
name: Preterm Birth
description: >
Delivery before 37 completed weeks of gestation, the dominant obstetric
consequence of intra-amniotic infection and inflammation.
phenotype_term:
preferred_term: Premature birth
term:
id: HP:0001622
label: Premature birth
evidence:
- reference: PMID:26428503
reference_title: "Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Chronic chorioamnionitis is the most common lesion in late spontaneous
preterm birth and is characterized by the infiltration of maternal CD8+ T
cells into the chorioamniotic membranes.
explanation: >-
Ties placental inflammatory lesions to spontaneous preterm birth.
- category: Neonatal
name: Early-Onset Neonatal Sepsis
description: >
Invasive bacterial infection of the newborn within the first 72 hours,
associated with both the clinical and histologic forms of the disease.
phenotype_term:
preferred_term: Neonatal sepsis
term:
id: HP:0040187
label: Neonatal sepsis
evidence:
- reference: PMID:33957655
reference_title: "Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Both histologic and clinical chorioamnionitis were associated with early-
and late-onset sepsis in neonates.
explanation: >-
Meta-analysis of human studies supporting the neonatal sepsis association
for both subtypes.
- category: Neonatal
name: Periventricular Leukomalacia
description: >
White-matter injury of the preterm brain, the imaging and pathological
correlate of the inflammatory brain-injury arm.
phenotype_term:
preferred_term: Periventricular leukomalacia
term:
id: HP:0006970
label: Periventricular leukomalacia
evidence:
- reference: PMID:10989405
reference_title: "Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Using a random effects model, clinical chorioamnionitis was significantly
associated with both cerebral palsy (RR, 1.9; 95% CI, 1.4-2.5) and cPVL
(RR, 3.0; 95% CI, 2.2-4.0) in preterm infants.
explanation: >-
Meta-analysis quantifying the association with cystic periventricular
leukomalacia in preterm infants.
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Neonates born with FIRS have a higher rate of complications, such as
early-onset neonatal sepsis, intraventricular hemorrhage, periventricular
leukomalacia, and death, than those born without FIRS.
explanation: >-
Associates the fetal inflammatory response with periventricular
leukomalacia.
- category: Neonatal
name: Intraventricular Hemorrhage
description: >
Germinal matrix and intraventricular hemorrhage of the preterm infant,
increased in the presence of fetal systemic inflammation.
phenotype_term:
preferred_term: Preterm intraventricular hemorrhage
term:
id: HP:0030747
label: Preterm intraventricular hemorrhage
evidence:
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Neonates born with FIRS have a higher rate of complications, such as
early-onset neonatal sepsis, intraventricular hemorrhage, periventricular
leukomalacia, and death, than those born without FIRS.
explanation: >-
Associates the fetal inflammatory response with intraventricular
hemorrhage.
- category: Long-term
name: Cerebral Palsy
description: >
Non-progressive motor disability, the long-term neurodevelopmental endpoint
of the inflammatory brain-injury pathway. The dismech Cerebral_Palsy entry
holds the reciprocal risk-factor evidence for this association.
phenotype_term:
preferred_term: Cerebral palsy
term:
id: HP:0100021
label: Cerebral palsy
evidence:
- reference: PMID:10989405
reference_title: "Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Using a random effects model, clinical chorioamnionitis was significantly
associated with both cerebral palsy (RR, 1.9; 95% CI, 1.4-2.5) and cPVL
(RR, 3.0; 95% CI, 2.2-4.0) in preterm infants.
explanation: >-
Meta-analysis quantifying the cerebral palsy association in preterm
infants. This is the same source cited from the reciprocal direction in
the dismech Cerebral_Palsy entry.
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Infants born to mothers with clinical chorioamnionitis near term are at
risk for early-onset neonatal sepsis and for long-term disability such as
cerebral palsy.
explanation: >-
Extends the association to infants born near term, not only preterm.
- category: Long-term
name: Chronic Lung Disease of Prematurity
description: >
Bronchopulmonary dysplasia. The association with chorioamnionitis is real on
pooled analysis but the same meta-analysis found strong publication bias and
declined to call it definitive, so the claim is deliberately not overstated
here.
phenotype_term:
preferred_term: Bronchopulmonary dysplasia
term:
id: HP:0006528
label: Chronic lung disease
evidence:
- reference: PMID:21697236
reference_title: "Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Despite a large body of evidence, CA cannot be definitively considered a
risk factor for BPD.
explanation: >-
Recorded as PARTIAL: the pooled association is significant but the authors
explicitly decline to call chorioamnionitis a definitive risk factor.
- category: Maternal
name: Postpartum Endometritis
description: >
Puerperal infection of the uterine lining, a maternal complication for which
postpartum antibiotic continuation is reserved.
phenotype_term:
preferred_term: Endometritis
term:
id: HP:0025636
label: Endometritis
evidence:
- reference: PMID:28742677
reference_title: "Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Maternal morbidity from intraamniotic infection also can be significant,
and may include dysfunctional labor requiring increased intervention,
postpartum uterine atony with hemorrhage, endometritis, peritonitis,
sepsis, adult respiratory distress syndrome and, rarely, death.
explanation: >-
Lists endometritis among the maternal complications.
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Clinical chorioamnionitis, the most common infection-related diagnosis in
labor and delivery units, is an antecedent of puerperal infection and
neonatal sepsis.
explanation: >-
Establishes puerperal infection as a maternal consequence.
- category: Clinical
name: Fetal Tachycardia
description: >
Fetal baseline heart rate above 160 beats per minute, one of the supporting
fetal signs in the clinical diagnostic criteria set.
phenotype_term:
preferred_term: Fetal tachycardia
term:
id: HP:6000264
label: Fetal tachycardia
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The condition is suspected when intrapartum fever is associated with two
other maternal and fetal signs of local or systemic inflammation (eg,
maternal tachycardia, uterine tenderness, maternal leukocytosis,
malodorous vaginal discharge or amniotic fluid, and fetal tachycardia).
explanation: >-
Lists fetal tachycardia among the defining supporting signs of the
clinical syndrome.
subtype: Clinical
- category: Clinical
name: Malodorous Amniotic Fluid or Vaginal Discharge
description: >
Purulent or foul-smelling amniotic fluid or cervical discharge. A specific
but late and insensitive sign, so its absence does not exclude the
diagnosis.
phenotype_term:
preferred_term: Malodorous vaginal discharge or amniotic fluid
term:
id: HP:0034269
label: Abnormal vaginal discharge
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The condition is suspected when intrapartum fever is associated with two
other maternal and fetal signs of local or systemic inflammation (eg,
maternal tachycardia, uterine tenderness, maternal leukocytosis,
malodorous vaginal discharge or amniotic fluid, and fetal tachycardia).
explanation: >-
Lists malodorous vaginal discharge or amniotic fluid among the defining
supporting signs.
subtype: Clinical
- category: Long-term
name: Retinopathy of Prematurity
description: >
Abnormal retinal vascular development in the preterm infant, listed among
the long-term sequelae of the fetal inflammatory response syndrome.
phenotype_term:
preferred_term: Retinopathy of prematurity
term:
id: HP:0500049
label: Retinopathy of prematurity
evidence:
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Survivors are at risk for long-term sequelae that may include
bronchopulmonary dysplasia, neurodevelopmental disorders, such as cerebral
palsy, retinopathy of prematurity, and sensorineuronal hearing loss.
explanation: >-
Lists retinopathy of prematurity among the long-term sequelae of the fetal
inflammatory response syndrome.
- category: Long-term
name: Sensorineural Hearing Loss
description: >
Cochlear or retrocochlear hearing impairment, listed among the long-term
sequelae of the fetal inflammatory response syndrome.
phenotype_term:
preferred_term: Sensorineural hearing loss
term:
id: HP:0000407
label: Sensorineural hearing impairment
evidence:
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Survivors are at risk for long-term sequelae that may include
bronchopulmonary dysplasia, neurodevelopmental disorders, such as cerebral
palsy, retinopathy of prematurity, and sensorineuronal hearing loss.
explanation: >-
Lists sensorineural hearing loss among the long-term sequelae of the fetal
inflammatory response syndrome. The source spells it sensorineuronal.
histopathology:
- name: Acute Chorioamnionitis, Funisitis and Chorionic Vasculitis
description: >
The defining acute inflammatory lesions of the placenta: diffuse
neutrophilic infiltration at different sites in the organ. Site determines
whose response it is, which is the whole diagnostic point. Neutrophils in
chorion and amnion are maternal; neutrophils in the umbilical cord
(funisitis) and chorionic plate vessels (chorionic vasculitis) are fetal.
Severity progresses from subchorionitis through chorioamnionitis to
necrotizing chorioamnionitis, and in the fetal compartment from umbilical
phlebitis through arteritis to necrotizing funisitis.
diagnostic: true
subtype: Histologic Acute
finding_term:
preferred_term: Acute histologic chorioamnionitis
term:
id: NCIT:C111944
label: Histologic Chorioamnionitis
notes: >-
Only the chorioamnionitis component is bindable. NCIT does have
NCIT:C97077 Funisitis and NCIT:C117324 Fetal Chorionic Vasculitis, but both
sit under NCIT:C2991 Disease or Disorder rather than under
NCIT:C83490 Histopathology Result, so neither is reachable from the
HistopathologyFindingTerm enum roots and neither can be bound here. That is
an upstream NCIT placement gap, not a curation choice.
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
These lesions include acute chorioamnionitis, funisitis, and chorionic
vasculitis and represent a host response (maternal or fetal) to a
chemotactic gradient in the amniotic cavity.
explanation: >-
Enumerates the acute placental lesions and frames them as host responses
to the amniotic chemotactic gradient.
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
While acute chorioamnionitis is evidence of a maternal host response,
funisitis and chorionic vasculitis represent fetal inflammatory responses.
explanation: >-
Establishes the maternal versus fetal attribution that the staging system
formalizes.
stages:
- name: Maternal Inflammatory Response
description: >
The maternal arm of the acute lesion, corresponding to the pathophysiology
node Maternal Inflammatory Response and Acute Chorioamnionitis, and to the
Histologic Acute subtype. It is staged by how far maternal neutrophils have
advanced from the decidual side toward the amniotic cavity, with a separate
two-tier grade for severity. This is the more reproducible of the two axes.
substages:
- name: MIR Stage 1
description: >
Acute subchorionitis or subchorionic chorionitis: maternal neutrophils
confined to the subchorionic fibrin and the chorionic plate, the earliest
recognizable maternal response.
- name: MIR Stage 2
description: >
Acute chorioamnionitis proper: neutrophils have advanced through the
chorionic connective tissue and into the amnion. This is the stage the
unqualified term chorioamnionitis usually denotes.
- name: MIR Stage 3
description: >
Necrotizing chorioamnionitis: amnionic epithelial necrosis, basement
membrane thickening, and karyorrhectic neutrophil debris, indicating a
prolonged rather than merely severe process.
evidence:
- reference: PMID:14708737
reference_title: "Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Grading and staging of maternal and fetal inflammatory responses was found
to be more reproducible using a two- versus three-tiered grading system
than a three- versus five-tiered staging system (overall agreement 81% vs.
71%).
explanation: >-
Society for Pediatric Pathology reproducibility study establishing that
the maternal and fetal inflammatory responses are separately graded and
staged, and quantifying observer agreement for each scheme.
notes: >-
The stage boundaries are carried as substage descriptions, which assert
nothing beyond the standard Amsterdam definitions and require no evidence.
The attached evidence covers only what the cited abstract actually supports:
that the maternal and fetal responses are separately graded and staged, and
how reproducible each scheme is. The full Amsterdam Stage 1-3 and Grade 1-2
text lives in the consensus chapter body rather than in any cached abstract,
so it is described but never quoted as evidence.
- name: Fetal Inflammatory Response
description: >
The fetal arm, corresponding to the pathophysiology node Fetal Inflammatory
Response with Funisitis and Chorionic Vasculitis, and to the Histologic
Acute subtype. It is staged by which fetal vessels neutrophils have entered.
It predicts neonatal outcome considerably better than the maternal stage,
because it reflects the fetus's own response rather than the mother's.
substages:
- name: FIR Stage 1
description: >
Chorionic vasculitis or umbilical phlebitis: fetal neutrophils in the
chorionic plate vessels or the umbilical vein only.
- name: FIR Stage 2
description: >
Umbilical arteritis: involvement of one or both umbilical arteries.
Arterial involvement matters because arterial blood is flowing from the
fetus, so it marks a more established systemic fetal response.
- name: FIR Stage 3
description: >
Necrotizing funisitis: concentric perivascular bands of neutrophil debris
and cellular necrosis in Wharton's jelly, indicating a chronic and
advanced fetal response and carrying the worst prognosis.
evidence:
- reference: PMID:14708737
reference_title: "Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Grading and staging of maternal and fetal inflammatory responses was found
to be more reproducible using a two- versus three-tiered grading system
than a three- versus five-tiered staging system (overall agreement 81% vs.
71%).
explanation: >-
Same reproducibility study, covering the fetal response as the second
separately staged axis.
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Funisitis and chorionic vasculitis are the hallmarks of the fetal
inflammatory response syndrome, a condition characterized by an elevation
in the fetal plasma concentration of interleukin-6
explanation: >-
Ties the fetal staging axis to the systemic fetal syndrome it marks.
environmental:
- name: Obstetric Instrumentation and Prolonged Labor
influences_mechanisms:
- target: Vaginal Dysbiosis and Cervical Barrier Breach
environmental_effect: TRIGGERS
causal_link_type: DIRECT
description: >-
Repeated vaginal examination and prolonged membrane exposure breach the
mechanical barrier itself, which is why the risk scales with the number
of examinations rather than with any single procedure. It targets the
barrier node rather than the invasion node downstream of it, so the
contrast with the periodontal route is preserved: instrumentation goes
through the cervical barrier, whereas oral organisms bypass it entirely.
evidence:
- reference: PMID:2782335
reference_title: "Risk factors for intraamniotic infection: a prospective epidemiologic study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Logistic regression analysis identified four variables independently associated with intraamniotic infection: the number of vaginal examinations, duration of ruptured membranes, use of internal monitors, and duration of total labor."
explanation: >-
Identifies the number of vaginal examinations among the variables
independently associated with intraamniotic infection, the ascending
route this node describes.
description: >
The dominant modifiable exposures here are procedural and mechanical rather
than chemical: repeated digital vaginal examinations, prolonged rupture of
membranes, internal fetal or uterine monitoring, and long total labor. Each
either breaches the cervical barrier or prolongs the breach, which is why
they act on the trigger node of this entry's pathograph and why minimizing
examinations after rupture is standard prevention advice.
presence: PRESENT
evidence:
- reference: PMID:2782335
reference_title: "Risk factors for intraamniotic infection: a prospective epidemiologic study."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Logistic regression analysis identified four variables independently
associated with intraamniotic infection: the number of vaginal
examinations, duration of ruptured membranes, use of internal monitors,
and duration of total labor.
explanation: >-
Prospective epidemiologic study identifying the four independent
procedural and labor-duration risk factors, all of which act on the
cervical-barrier trigger node.
- name: Oral and Periodontal Infection
influences_mechanisms:
- target: Ascending Microbial Invasion of the Amniotic Cavity
environmental_effect: PREDISPOSES
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
A haematogenous rather than ascending route, and the exception to this
entry's usual model: oral Fusobacterium can seed the amniotic cavity
from the bloodstream. Recorded as predisposing because the evidence is a
single case demonstration rather than an established pathway.
evidence:
- reference: PMID:23115747
reference_title: "Acute chorioamnionitis at term caused by the oral pathogen Fusobacterium nucleatum."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In addition to its role in periodontal disease and preterm birth, our case demonstrates that intrauterine infection with Fusobacterium nucleatum can result in severe disease at term."
explanation: >-
Reports a case of intrauterine infection with Fusobacterium linked to
periodontal disease, a documented but singular demonstration of the
oral route.
description: >
Periodontal disease provides a hematogenous rather than ascending route into
the amniotic cavity, which is how an oral anaerobe such as Fusobacterium
nucleatum reaches the fetal membranes. This is the documented exception to
the ascending-infection route that the rest of the entry models.
presence: PRESENT
evidence:
- reference: PMID:23115747
reference_title: "Acute chorioamnionitis at term caused by the oral pathogen Fusobacterium nucleatum."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In addition to its role in periodontal disease and preterm birth, our case
demonstrates that intrauterine infection with Fusobacterium nucleatum can
result in severe disease at term.
explanation: >-
Case report of acute chorioamnionitis at term caused by an oral pathogen,
supporting the periodontal-hematogenous exposure route. A single case, so
the exposure is recorded without any frequency claim.
biochemical:
- name: Amniotic Fluid Interleukin-6
presence: INCREASED
notes: >-
The operational gold standard for intra-amniotic inflammation. An elevated
amniotic fluid IL-6 concentration defines the inflammatory state regardless
of whether organisms are recoverable, which is precisely what allows sterile
intra-amniotic inflammation to be distinguished from intra-amniotic
infection.
evidence:
- reference: PMID:34238107
reference_title: "Intra-amniotic infection and sterile intra-amniotic inflammation in women with preterm labor with intact membranes are associated with a higher rate of Ureaplasma species DNA presence in the cervical fluid."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Intra-amniotic inflammation was determined based on the concentration of
interleukin-6 in the amniotic fluid.
explanation: >-
Human cohort using amniotic fluid IL-6 as the defining marker of
intra-amniotic inflammation.
- name: Amniotic Fluid Matrix Metalloproteinase-8
presence: INCREASED
notes: >-
Neutrophil collagenase released into amniotic fluid, serving both as a
diagnostic marker of intra-amniotic infection and as the effector of membrane
matrix degradation. A rapid bedside test format exists.
evidence:
- reference: PMID:11717662
reference_title: "Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our results indicate that matrix metalloproteinase-8 is highly correlated
with intra-amniotic infection
explanation: >-
Human case-control study establishing MMP-8 as a marker of intra-amniotic
infection.
- name: Fetal Plasma Interleukin-6
presence: INCREASED
notes: >-
Elevated fetal or umbilical cord plasma IL-6 is the defining biochemical
criterion of the fetal inflammatory response syndrome and the best available
biochemical predictor of neonatal outcome.
evidence:
- reference: PMID:33164775
reference_title: "The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
FIRS can be diagnosed by an increased concentration of umbilical cord
plasma or serum acute phase reactants such as C-reactive protein or
cytokines (e.g., interleukin-6).
explanation: >-
Defines cord plasma IL-6 as the diagnostic criterion for the fetal
syndrome.
prevalence:
- population: Term placentas
measure_type: BIRTH_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 4000.0
rate_low: 3000.0
rate_high: 5000.0
subtype: Histologic Acute
notes: >-
Histologic acute chorioamnionitis present in 3-5% of term placentas.
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The prevalence of chorioamnionitis is a function of gestational age at
birth, and present in 3-5% of term placentas and in 94% of placentas
delivered at 21-24 weeks of gestation.
explanation: >-
Source for the term-placenta histologic prevalence.
- population: Placentas delivered at 21-24 weeks of gestation
measure_type: BIRTH_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 94000.0
subtype: Histologic Acute
notes: >-
Histologic acute chorioamnionitis present in 94% of placentas delivered at
21-24 weeks. The steep inverse gradient with gestational age is the single
most striking epidemiological feature of the lesion.
evidence:
- reference: PMID:26428501
reference_title: "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The prevalence of chorioamnionitis is a function of gestational age at
birth, and present in 3-5% of term placentas and in 94% of placentas
delivered at 21-24 weeks of gestation.
explanation: >-
Source for the extreme-preterm histologic prevalence.
- population: Women with preterm labor and intact membranes
measure_type: POINT_PREVALENCE
prevalence_class: ABOVE_1_IN_1000
rate_per_100000: 14000.0
notes: >-
Intra-amniotic infection identified in 14% and sterile intra-amniotic
inflammation in 25% of 115 women with preterm labor and intact membranes.
Deliberately left unassigned to a subtype. This is amniocentesis-detected
subclinical intra-amniotic infection in women presenting with preterm
labor, which is neither the Clinical subtype (an overt intrapartum syndrome
defined by fever plus supporting signs) nor a placental-histology figure.
It is a fourth thing the three-subtype axis does not cover, and forcing it
into one of them would misrepresent what was measured.
evidence:
- reference: PMID:34238107
reference_title: "Intra-amniotic infection and sterile intra-amniotic inflammation in women with preterm labor with intact membranes are associated with a higher rate of Ureaplasma species DNA presence in the cervical fluid."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Intra-amniotic infection and sterile inflammation were identified in 14%
(16/115) and 25% (29/115) of the women, respectively.
explanation: >-
Human cohort quantifying demonstrable infection versus sterile
inflammation.
treatments:
- name: Intrapartum Ampicillin and Gentamicin
description: >
The standard intrapartum regimen when intraamniotic infection is suspected or
confirmed, given to reduce neonatal sepsis. Treatment is directed at the
ascending-invasion node rather than at the inflammatory response itself.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: ampicillin
term:
id: CHEBI:28971
label: ampicillin
- preferred_term: gentamicin
term:
id: CHEBI:17833
label: gentamycin
target_mechanisms:
- target: Ascending Microbial Invasion of the Amniotic Cavity
treatment_effect: INHIBITS
description: >
Antibiotics act on the invading organisms rather than on the downstream
inflammatory cascade.
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Intrapartum antibiotic administration is the standard treatment to reduce
neonatal sepsis.
explanation: >-
Establishes intrapartum antibiotics as standard therapy and states the
outcome they target.
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Treatment with ampicillin and gentamicin have been recommended by
professional societies
explanation: >-
Identifies the specific first-line agents curated here.
notes: >-
Gentamicin is bound to the CHEBI base term whose canonical label is
gentamycin; the clinical spelling is retained in preferred_term. The
aminoglycoside component is also the one genuinely actionable
pharmacogenomic consideration in this regimen, via MT-RNR1-associated
aminoglycoside ototoxicity.
- name: Anaerobic Coverage for Cesarean Delivery
description: >
Clindamycin or metronidazole added at cord clamp when delivery is by
cesarean, extending coverage to the anaerobes prominent in polymicrobial
intraamniotic infection.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: clindamycin
term:
id: CHEBI:3745
label: clindamycin
- preferred_term: metronidazole
term:
id: CHEBI:6909
label: metronidazole
target_mechanisms:
- target: Ascending Microbial Invasion of the Amniotic Cavity
treatment_effect: INHIBITS
description: >
Extends antimicrobial coverage to the anaerobic component of the
polymicrobial flora.
evidence:
- reference: PMID:33007269
reference_title: "Management of clinical chorioamnionitis: an evidence-based approach."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In both study groups, patients who underwent cesarean delivery also
received clindamycin after cord clamping to extend coverage for anaerobic
organisms.
explanation: >-
States both the timing (after cord clamping, at cesarean) and the
rationale (anaerobic coverage) for this treatment.
- name: Ceftriaxone, Clarithromycin and Metronidazole Eradication Regimen
description: >
A regimen selected to cover the genital mycoplasmas that dominate the
microbiology and that are not covered by ampicillin. Reported to reduce
intra-amniotic inflammation and infection on follow-up amniocentesis, which
challenges the default assumption that demonstrated intra-amniotic infection
always mandates immediate delivery.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: ceftriaxone
term:
id: CHEBI:29007
label: ceftriaxone
- preferred_term: clarithromycin
term:
id: CHEBI:3732
label: clarithromycin
- preferred_term: metronidazole
term:
id: CHEBI:6909
label: metronidazole
target_mechanisms:
- target: Ascending Microbial Invasion of the Amniotic Cavity
treatment_effect: INHIBITS
description: >
Directed specifically at eradicating the organisms occupying the amniotic
cavity, including genital mycoplasmas.
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
We have used the combination of ceftriaxone, clarithromycin, and
metronidazole, which has been shown to eradicate intraamniotic infection
with microbiologic studies.
explanation: >-
Source for the composition and the eradication rationale of this regimen.
- reference: PMID:26441216
reference_title: "A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The rates of intra-amniotic inflammation and intra-amniotic
inflammation/infection in patients who received regimen 2 decreased during
treatment from 68.8% to 52.1% and from 75% to 54.2%, respectively.
explanation: >-
Retrospective cohort with serial amniocenteses quantifying the fall in
intra-amniotic inflammation and infection under this regimen, whereas the
comparator ampicillin and cephalosporin regimen showed rising rates.
- name: Antenatal Corticosteroids
description: >
Betamethasone or dexamethasone for fetal maturation. Administered at eligible
gestational ages even in the presence of chorioamnionitis, where the net
benefit favours administration.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: betamethasone
term:
id: CHEBI:3077
label: betamethasone
target_mechanisms:
- target: Fetal Pulmonary Inflammation and Arrested Alveolarization
treatment_effect: MODULATES
description: >
Accelerates fetal surfactant production and lung maturation, acting on the
pulmonary arm of the fetal inflammatory response rather than on the
infection itself.
evidence:
- reference: PMID:33007269
reference_title: "Management of clinical chorioamnionitis: an evidence-based approach."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Current evidence suggests that the administration of antenatal
corticosteroids for fetal lung maturation and of magnesium sulfate for
fetal neuroprotection to patients with clinical chorioamnionitis between
24 0/7 and 33 6/7 weeks of gestation
explanation: >-
Supports administering antenatal corticosteroids specifically in the
setting of clinical chorioamnionitis, and bounds the gestational-age
window in which it is advised.
- name: Group B Streptococcal Screening and Intrapartum Antibiotic Prophylaxis
description: >
Universal antenatal vaginal-rectal GBS culture at 36 0/7 to 37 6/7 weeks,
with intrapartum penicillin for those who screen positive. This is
prevention rather than treatment: it targets the ascending-invasion node
before it is reached, and it is the reason Streptococcus agalactiae is a far
less common cause of early-onset neonatal sepsis than its virulence would
otherwise predict.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: penicillin G
term:
id: CHEBI:18208
label: benzylpenicillin
target_mechanisms:
- target: Ascending Microbial Invasion of the Amniotic Cavity
treatment_effect: INHIBITS
description: >
Suppresses maternal genital-tract GBS carriage during labor, preventing
the ascent and vertical transmission that would otherwise seed the
amniotic cavity and the newborn.
evidence:
- reference: PMID:31977795
reference_title: "Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The American College of Obstetricians and Gynecologists now recommends
performing universal GBS screening between 36 0/7 and 37 6/7 weeks of
gestation.
explanation: >-
Establishes the universal screening arm of this intervention and its
timing.
- reference: PMID:31977795
reference_title: "Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
All women whose vaginal-rectal cultures at 36 0/7-37 6/7 weeks of
gestation are positive for GBS should receive appropriate intrapartum
antibiotic prophylaxis unless a prelabor cesarean birth is performed in
the setting of intact membranes.
explanation: >-
Establishes the prophylaxis arm and the single exception to it.
- reference: PMID:31977795
reference_title: "Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In the absence of intrapartum antibiotic prophylaxis, 1-2% of those
newborns will develop GBS EOD.
explanation: >-
Quantifies the untreated baseline risk this intervention removes.
notes: >-
The frequently quoted population effect of universal screening plus
prophylaxis (early-onset GBS disease falling from roughly 1.8 to 0.23 per
1,000 live births) comes from CDC surveillance reports rather than from this
committee opinion, so it is described here but not asserted as a quoted
evidence claim.
- name: Delivery
description: >
Delivery is definitive therapy for the maternal disease. Importantly,
chorioamnionitis by itself is not an indication for cesarean delivery, and
the route should be decided on standard obstetric grounds.
therapeutic_modality: OTHER
treatment_term:
preferred_term: Obstetric delivery
evidence:
- reference: PMID:28742677
reference_title: "Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Intraamniotic infection alone is rarely, if ever, an indication for
cesarean delivery.
explanation: >-
Professional-society statement constraining how this treatment should be
applied; recorded so the entry does not imply that the diagnosis mandates
operative delivery.
notes: >-
Deliberately left without a `term:` binding. NCIT has no clinical-action
term for obstetric delivery, and the nearest candidate (NCIT:C15329
Surgical Procedure) would contradict this treatment's own evidence, which
states that intraamniotic infection is rarely an indication for cesarean.
Per CLAUDE.md, omitting the term is preferred over a misleading one;
`therapeutic_modality` is OTHER for the same reason. A candidate for an NCIT
new-term request. This treatment covers the delivery decision generally, not
cesarean specifically.
diagnosis:
- name: Amniocentesis with Amniotic Fluid Analysis
description: >
Definitive diagnosis in uncertain cases rests on sampling amniotic fluid and
testing in parallel for organisms and for inflammation, because either can be
present without the other.
evidence:
- reference: PMID:38233317
reference_title: "Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In cases of uncertainty, a definitive diagnosis can be made by analyzing
amniotic fluid with methods to detect bacteria (Gram stain, culture, or
microbial nucleic acid) and inflammation (white blood cell count, glucose
concentration, interleukin-6, interleukin-8, matrix metalloproteinase-8).
explanation: >-
Specifies the dual microbiological and inflammatory testing strategy.
- name: Placental Histopathological Examination
description: >
Examination of the placenta and membranes after delivery, reported using the
Amsterdam consensus criteria, which stage and grade the maternal and fetal
inflammatory responses separately. This is the reference standard for the
lesion but is by nature retrospective.
evidence:
- reference: PMID:27223167
reference_title: "Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The terminology and microscopic descriptions for maternal vascular
malperfusion, fetal vascular malperfusion, delayed villous maturation,
patterns of ascending intrauterine infection, and villitis of unknown
etiology were agreed upon.
explanation: >-
Amsterdam consensus supplying the standardized reporting criteria for
ascending intrauterine infection patterns.
discussions:
- discussion_id: chorio_sterile_vs_infectious_boundary
kind: OPEN_QUESTION
status: OPEN
prompt: >-
If sterile intra-amniotic inflammation is more common than demonstrable
intra-amniotic infection in preterm labor and produces an indistinguishable
placental lesion, is chorioamnionitis correctly classified as an infectious
disease at all?
attaches_to:
- pathophysiology#Alarmin Release and Sterile Intra-amniotic Inflammation
- pathophysiology#Ascending Microbial Invasion of the Amniotic Cavity
rationale: >-
This entry is filed under Infectious Disease and MONDO classifies
MONDO:0000409 partly under bacterial infectious disease, yet a human cohort
found sterile inflammation in 25% versus demonstrable infection in 14% of
women with preterm labor. The classification is defensible historically but
sits uneasily with the mechanism as currently understood, and the entry
models the two triggers as parallel arms converging on shared receptor
signaling rather than forcing one to be primary.
- discussion_id: chorio_bpd_association_strength
kind: CONTROVERSY
status: OPEN
prompt: >-
Is chorioamnionitis a genuine independent risk factor for bronchopulmonary
dysplasia, or is the reported association an artifact of publication bias
and residual confounding by gestational age?
attaches_to:
- pathophysiology#Fetal Pulmonary Inflammation and Arrested Alveolarization
rationale: >-
The largest meta-analysis found a significant pooled association but also
strong evidence of publication bias, more conservative adjusted estimates,
and infants exposed to chorioamnionitis being younger and lighter at birth.
Its authors explicitly declined to call chorioamnionitis a definitive risk
factor. The corresponding evidence items are recorded as PARTIAL rather than
SUPPORT.
evidence:
- reference: PMID:21697236
reference_title: "Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Despite a large body of evidence, CA cannot be definitively considered a
risk factor for BPD.
explanation: >-
The meta-analysis authors' own statement of the unresolved status of this
association.
- discussion_id: chorio_placental_architecture_model_mismatch
kind: HUMAN_MODEL_MISMATCH
status: OPEN
prompt: >-
Do results from sheep and other large-animal models of intra-amniotic
inflammation transfer to human disease, given that their placental
architecture is epitheliochorial and cotyledonary rather than hemochorial
and discoid?
attaches_to:
- pathophysiology#Fetal Pulmonary Inflammation and Arrested Alveolarization
- pathophysiology#Microglial Activation and Preterm White Matter Injury
rationale: >-
Much of the mechanistic evidence for the fetal lung and brain injury arms
comes from intra-amniotic endotoxin models in sheep, which are the workhorse
for fetal physiology precisely because the fetus is large enough to
instrument. But an epitheliochorial placenta interposes more cellular layers
between maternal blood and fetus than the human hemochorial placenta does,
which plausibly alters both microbial access and cytokine transfer. The
mismatch concerns translational validity, not absence of evidence, so it is
recorded as HUMAN_MODEL_MISMATCH rather than KNOWLEDGE_GAP. Mouse models
carry a separate mismatch, since murine parturition depends on progesterone
withdrawal and human parturition does not.
- discussion_id: chorio_no_causal_genes
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
Is there any replicated host-genetic contribution to chorioamnionitis
susceptibility?
rationale: >-
Chorioamnionitis is an acquired condition with no causal genes, no OMIM
entry, and no genetic testing indication. A candidate-gene literature exists
for inflammatory mediators such as TNF, IL6, IL1RN and TLR4 in relation to
preterm birth and intra-amniotic inflammation, but it is small and largely
unreplicated. No genetic block is curated in this entry rather than
populating one from unreplicated single studies. This note exists so that a
future curator does not read the empty genetic section as an oversight.
notes: >-
Scope decisions worth recording. First, this entry deliberately keeps three
things distinct that clinical usage blurs: the intrapartum clinical syndrome,
the acute histologic placental lesion, and chronic chorioamnionitis, which is
a lymphocytic lesion of maternal anti-fetal rejection that merely shares the
name. They are modeled as subtypes rather than as one blended graph. Second,
the fetal inflammatory response syndrome is curated here as a pathophysiology
node rather than as a separate disease entry, because it is the mechanistic
bridge from this exposure to the neonatal outcomes; the downstream diseases
themselves (cerebral palsy, bronchopulmonary dysplasia) stay in their own
entries, and Cerebral_Palsy already carries the reciprocal risk-factor
evidence from the same meta-analysis (PMID:10989405). Third, only FIRS type I
(the acute, cord-IL-6-defined, funisitis-associated form) is modeled here;
FIRS type II, a chronic CXCL10-associated form tied to maternal anti-fetal
rejection, belongs with chronic chorioamnionitis and villitis of unknown
etiology rather than with the acute infectious entity, and is deliberately not
merged into the Fetal Inflammatory Response Syndrome node.
Ontology gaps found while curating, all verified rather than assumed. HPO has
no term for chorioamnionitis or funisitis. The obvious term for maternal fever
in pregnancy (HP:0030244) sits outside the curatable Phenotypic abnormality
hierarchy, under Past medical history. HPO has no uterine or fundal tenderness
term either (only nipple, scalp, costovertebral-angle, cervical-motion and
peroneal tenderness), so that clinical criterion is described in the Clinical
subtype and in the diagnostic criteria snippets but is not curated as a bound
phenotype. HPO has no bronchopulmonary dysplasia term, so the BPD phenotype is
bound to the parent HP:0006528 Chronic lung disease. NCIT has no obstetric
delivery clinical-action term. And although NCIT:C111944 Histologic
Chorioamnionitis is correctly placed under NCIT:C83490 Histopathology Result
and is bound on the histopathology record, its two companion lesions,
NCIT:C97077 Funisitis and NCIT:C117324 Fetal Chorionic Vasculitis, sit under
NCIT:C2991 Disease or Disorder instead, so neither is reachable from the
HistopathologyFindingTerm enum roots and neither can be bound as a
histopathological finding. That is an upstream NCIT placement gap rather than
a missing term. These are all recorded here rather than papered over with
poorly fitting bindings, and each is a reasonable upstream new-term or
reclassification request.
Deliberately out of scope: the additional minor amniotic-cavity isolates
(Gardnerella, Sneathia, Bacteroides, Candida, Listeria, Trichomonas) are real
but contribute no distinct mechanism beyond the six curated agents; the
differential diagnosis list, animal models, and clinical trials are left for a
follow-up pass rather than populated thinly here.
Prepared: 2026-08-04 · Target: dismech knowledge base entry (kb/disorders/Chorioamnionitis.yaml) · Category: Infectious
Read this first — snippet discipline. Every quoted passage below is tagged
[VERBATIM](pulled from the PubMed abstract page and believed to be an exact substring) or[PARAPHRASE](the fetch returned a summarizer's rewording — do not paste it into anevidence.snippet:field). Per the dismech SOP, runjust fetch-reference PMID:XXXXXXXandjust validate-referenceson every citation before committing. Every ontology ID in this report is a candidate and must survivejust validate-terms; I've flagged confidence explicitly in §16.
Chorioamnionitis is inflammation of the fetal membranes — the amnion and chorion — and, by extension, of the amniotic fluid, umbilical cord, decidua and sometimes the fetus itself. Think of the amniotic sac as a sealed fermentation vessel: it's supposed to be a closed, low-microbe compartment, and chorioamnionitis is what happens when something breaches the seal (or when the vessel's own tissue starts screaming without any invader at all). The condition sits at the intersection of infection, sterile inflammation, and the physiological inflammatory program of labor itself, which is exactly why its nomenclature has been fought over for a decade.
Three overlapping entities travel under the name, and conflating them is the single biggest curation trap here:
| Entity | Basis of diagnosis | Notes |
|---|---|---|
| Clinical chorioamnionitis / intraamniotic infection (IAI) | Maternal fever + supporting clinical signs, intrapartum | The bedside syndrome. Poorly specific for actual infection. |
| Histologic (acute) chorioamnionitis | Placental pathology — neutrophil infiltration of chorion/amnion | Frequently silent; the majority of cases are clinically undiagnosed. |
| Intra-amniotic inflammation (microbial-associated vs. sterile) | Amniotic fluid IL-6 / MMP-8 ± culture / PCR-ESI-MS | The mechanistic ground truth; requires amniocentesis. |
ACOG's definition: "Intraamniotic infection, also known as chorioamnionitis, is an infection with resultant inflammation of any combination of the amniotic fluid, placenta, fetus, fetal membranes, or decidua." [VERBATIM] — ACOG Committee Opinion No. 712, Obstet Gynecol 2017;130(2):e95-e101 (PMID:28742677).
In January 2015 an NICHD expert panel convened specifically because the word "chorioamnionitis" had become a semantic swamp:
"The panel noted that the term chorioamnionitis has been used to label a heterogeneous array of conditions characterized by infection and inflammation or both with a consequent great variation in clinical practice for mothers and their newborns. Therefore, the panel proposed to replace the term chorioamnionitis with a more general, descriptive term: 'intrauterine inflammation or infection or both,' abbreviated as 'Triple I.'... It is particularly important to recognize that an isolated maternal fever is not synonymous with chorioamnionitis."
[VERBATIM]— Higgins RD, Saade G, Polin RA, et al. Obstet Gynecol 2016;127(3):426-436 (PMID:26855098).
Triple I diagnostic tiers (NICHD 2016): - Isolated maternal fever — oral temp ≥39.0 °C once, or 38.0–38.9 °C persisting on repeat at 30 min. No other findings. - Suspected Triple I — fever plus ≥1 of: baseline fetal tachycardia (>160 bpm for ≥10 min); maternal WBC >15,000/mm³ without corticosteroids; definite purulent cervical discharge. - Confirmed Triple I — suspected Triple I plus objective laboratory confirmation: positive amniotic fluid Gram stain, low AF glucose, positive AF culture, or placental pathology showing diagnostic infection/inflammation.
ACOG (CO 712, 2017) then softened this back toward practical bedside use: suspected IAI is diagnosed when "the maternal temperature is greater than or equal to 39.0°C or when the maternal temperature is 38.0–38.9°C and one additional clinical risk factor is present." [VERBATIM] (PMID:28742677). Note that ACOG deliberately kept the term "intraamniotic infection" rather than adopting "Triple I" — the two vocabularies coexist in current literature. Adoption of Triple I has been patchy, and dismech should probably curate the entity under the historical name with both definitional frameworks captured as definitions[] blocks.
| System | Identifier | Notes |
|---|---|---|
| MONDO | MONDO:0000409 — "chorioamnionitis" | Confirmed against OLS4. Definition: "a morphologic finding indicating inflammation of the fetal sac membranes". Use this as disease_term. Per your new-mondo-term-ols-cache-miss memory, seed both DiseaseTerm and DiseaseOrSubtypeTerm enum caches. |
| ICD-10-CM | O41.12- "Chorioamnionitis" | Non-billable at 5 characters; trimester-specific children O41.121x / .122x / .123x / .129x, plus fetus-identifier 7th characters. Neonatal-side code: P02.7 ("Newborn affected by chorioamnionitis"). |
| ICD-11 | JA85.1 / JA85 (Infection of amniotic sac and membranes) | Verify against the WHO ICD-11 browser before curating. |
| MeSH | D002821 "Chorioamnionitis" | MeSH scope note: inflammation of chorion and amnion with connected tissues including fetal vessels and umbilical cord, often from ascending intrauterine infection. |
| SNOMED CT | 11612004 "Chorioamnionitis" | Verify; SNOMED is guide-only per dismech policy. |
| OMIM | None — not a Mendelian disorder | |
| Orphanet | None — not a rare disease | Do not attempt an ORPHA: reference here. |
| DOID | DOID:13892 (chorioamnionitis) | Cross-referenced by MONDO. |
Amnionitis · intraamniotic infection (IAI) · intra-amniotic infection · intrauterine infection · amniotic infection syndrome · "Triple I" (intrauterine inflammation or infection or both) · acute chorioamnionitis (histologic) · membranitis · placental acute inflammation · ascending intrauterine infection. Related-but-distinct terms that should not be merged: funisitis (umbilical cord inflammation — a fetal response), chorionic vasculitis, deciduitis, villitis of unknown etiology (chronic, non-infectious, different lesion class), chronic chorioamnionitis (a distinct lymphocytic lesion of late preterm birth).
Both individual-patient and aggregate. Clinical chorioamnionitis is a routine EHR/administrative diagnosis (ICD-10 O41.12-, present in birth certificate data and in large claims/registry sets like NIS, Kaiser, Consortium on Safe Labor), which makes it a good candidate for a computable phenotype definitions[] block. The mechanistic literature, by contrast, is dominated by a small number of amniocentesis-based cohorts (chiefly the NICHD Perinatology Research Branch, Wayne State/Detroit and Seoul National University), which are individual-patient but highly selected. Placental pathology data come from institutional pathology series standardized (since 2016) by the Amsterdam consensus.
Chorioamnionitis is not a genetic disease. It is an acquired, largely infectious/inflammatory condition with four recognized causal routes and one large sterile category.
Route 1 — Ascending infection from the lower genital tract (dominant, ~majority of preterm cases). Organisms move cervix → choriodecidual space → chorion/amnion → amniotic fluid → fetus. Romero's canonical staging:
Histologic progression follows the same order — chorio-deciduitis is the early stage, chorio-deciduo-amnionitis the advanced stage of ascending intrauterine infection (PMID:26574743).
Route 2 — Hematogenous / transplacental. Rare but important. Listeria monocytogenes is the archetype; recent molecular work supports hematogenous dissemination on the basis of "acute intervillositis and the detection of L. monocytogenes in the amniotic fluid and intervillous space of the placenta combined with the absence of this organism in the vagina" [PARAPHRASE — reverify] (PMID:40643048). Also Treponema pallidum, Mycobacterium tuberculosis, Brucella, Coxiella burnetii, and some viruses.
Route 3 — Iatrogenic / retrograde. Amniocentesis, chorionic villus sampling, fetoscopy, cerclage placement, intrauterine transfusion, retained IUD, amnioinfusion, internal fetal/uterine monitoring. Retrograde spread from the fallopian tubes into the peritoneal cavity is a fourth theoretical route (rarely documented).
Route 4 — Sterile intra-amniotic inflammation (no organism at all). This is the plot twist of the last fifteen years and it must be represented in the pathograph. In preterm labor with intact membranes:
"(i) The frequency of sterile intra-amniotic inflammation was significantly greater than that of microbial-associated intra-amniotic inflammation [26% (35/135) versus 11% (15/135); (P = 0.005)], (ii) patients with sterile intra-amniotic inflammation delivered at comparable gestational ages had similar rates of acute placental inflammation and adverse neonatal outcomes as patients with microbial-associated intra-amniotic inflammation, and (iii) patients with sterile intra-amniotic inflammation and high AF concentrations of HMGB1 (≥8.55 ng/mL) delivered earlier than those with low AF concentrations of HMGB1 (P = 0.02)."
[VERBATIM]— Romero R, Miranda J, Chaiworapongsa T, et al. Am J Reprod Immunol 2014;72(5):458-74 (PMID:25078709).
Route 5 (term-specific) — epidural-associated systemic maternal inflammation. At term, "clinical chorioamnionitis" is frequently neither infection nor even intra-amniotic: "Clinical chorioamnionitis is a syndrome caused by intraamniotic infection, sterile intraamniotic inflammation (inflammation without bacteria), or systemic maternal inflammation induced by epidural analgesia." [PARAPHRASE — reverify] — Jung E, Romero R, et al. Am J Obstet Gynecol 2024;230(3S):S807-S840 (PMID:38233317). Epidural-related fever is associated with elevated serum IL-6 and IL-8 and is essentially never microbial (PMID:21343762); one term series found grade 1–2 histologic chorioamnionitis in 34% of placentas with actual infection in only 4%.
Amniotic fluid isolates in preterm labor, in rough order of frequency: genital mycoplasmas — Ureaplasma urealyticum / Ureaplasma parvum (the single most common), Mycoplasma hominis; anaerobes — Fusobacterium nucleatum, Sneathia (Leptotrichia) sanguinegens, Bacteroides spp., Peptostreptococcus; facultative organisms — Gardnerella vaginalis, Streptococcus agalactiae (GBS), Escherichia coli, Enterococcus, Streptococcus anginosus group; fungi — Candida albicans (strongly associated with cerclage and retained IUD). Infection is usually polymicrobial.
Molecular methods substantially outperform culture: 16S rRNA sequencing detects uncultivable organisms including Sneathia, Leptotrichia, Bergeyella, Clostridiales, and oral-origin taxa (PMID:19144804, J Clin Microbiol 2008). Fusobacterium nucleatum is a periodontal organism, supporting the oral-hematogenous seeding hypothesis for a subset of cases.
Obstetric / mechanical (strongest, and mostly modifiable-ish):
| Risk factor | Direction/effect |
|---|---|
| Prolonged rupture of membranes (>18–24 h) | Chorioamnionitis in ~40% of PROM persisting >24 h |
| Prolonged labor, especially prolonged second stage | Strong, dose-dependent |
| Multiple digital vaginal examinations (esp. after ROM) | Dose-dependent |
| Nulliparity | Consistent |
| Internal fetal/uterine monitoring | Consistent |
| Meconium-stained amniotic fluid | Consistent (and bidirectional — inflammation → meconium passage) |
| Epidural analgesia | Strongly associated with fever, weakly/not with true infection |
| Labor induction / augmentation, amnioinfusion, cerclage | Moderate |
Microbiological/colonization: GBS colonization, bacterial vaginosis, Trichomonas vaginalis, Neisseria gonorrhoeae, Chlamydia trachomatis, cervical insufficiency with exposed membranes, short cervix, prior preterm birth, periodontal disease.
Host/demographic: young maternal age; nulliparity; obesity (high BMI); smoking; alcohol; immunocompromise (HIV — histologic acute chorioamnionitis prevalence studied in Ugandan HIV+ cohorts, PMC6459589); anemia; low socioeconomic status; African-American ancestry (confounded by access and by BV prevalence); prior clinical chorioamnionitis (population-based recurrence risk documented in Washington State 1989–2008, PMC3587161).
Gestational age is the single most powerful "risk factor" for the histologic lesion. Histologic acute chorioamnionitis prevalence is "3-5% at term, increasing to 94% at 21-24 weeks" [PARAPHRASE — reverify] — Kim CJ, Romero R, et al. Am J Obstet Gynecol 2015;213(4 Suppl):S29-52 (PMID:26428501). This inverse relationship is the most important epidemiological fact about the disease.
PARTIAL or omitted.The best-characterized GxE signal in this space is TNF genotype × bacterial vaginosis:
Maternal carriers of the TNF-2 allele (TNF −308A) had increased risk of spontaneous preterm birth (OR 2.7, 95% CI 1.7–4.5); "The association between TNF-2 and preterm birth was modified by bacterial vaginosis, with those having a susceptible genotype and bacterial vaginosis showing increased odds of preterm birth compared with those who did not (OR 6.1, 95% CI 1.9-21.0)"
[PARAPHRASE — reverify]— Macones GA, et al. Am J Obstet Gynecol 2004 (PMID:15284722).
This is a genuinely useful dismech pattern: environmental exposure (BV) × host inflammatory genotype → amplified inflammatory response → preterm birth. Caveat it heavily — a subsequent meta-analysis found no statistically significant association between TNF −308G>A and preterm birth overall, and later work (PMID:15507966) implicated TNF −863 rather than −308. Curate as an EMERGING/contested hypothesis with an explicit KNOWLEDGE_GAP discussion, not as settled mechanism.
| Phenotype | Category | Frequency | Candidate HPO |
|---|---|---|---|
| Maternal fever (≥39.0 °C once, or 38.0–38.9 °C sustained) | Clinical sign | Obligate for clinical dx (~100% by definition) | HP:0001945 Fever |
| Maternal tachycardia (>100 bpm) | Clinical sign | Frequent (~50–80%) | HP:0001649 Tachycardia |
| Fetal tachycardia (baseline >160 bpm ≥10 min) | Clinical sign | Frequent (~40–70%) | Verify — "Fetal tachycardia" term needed |
| Uterine fundal tenderness | Symptom/sign | Occasional (~4–25%) | No good HPO term |
| Purulent or malodorous amniotic fluid / cervical discharge | Clinical sign | Occasional (~5–22%) | Verify vaginal-discharge term |
| Maternal leukocytosis (WBC >15,000/mm³) | Lab abnormality | Frequent (~70–90%) | HP:0001974 Leukocytosis |
| Elevated CRP | Lab abnormality | Frequent | HP:0011227 Elevated circulating C-reactive protein concentration |
| Reduced uterine contractility / dysfunctional labor | Physical manifestation | Frequent | No clean HPO term — model as pathophysiology node |
| Maternal sepsis (rare, severe) | Clinical | Rare (<1%) | HP:0100806 Sepsis |
Note that the classic "malodorous fluid + uterine tenderness" triad is a late and insensitive finding; most cases present as fever plus tachycardia in a laboring nullipara with an epidural.
| Phenotype | Category | Frequency | Candidate HPO |
|---|---|---|---|
| Preterm birth | Clinical | ~40–70% of preterm births have intrauterine infection/inflammation | HP:0001622 Premature birth |
| Premature rupture of membranes / PPROM | Clinical | Very frequent as both cause and consequence | HP:0001788 Premature rupture of membranes |
| Early-onset neonatal sepsis | Clinical | ~1–4% of exposed term newborns; higher preterm | HP:0100806 Sepsis (+ neonatal onset qualifier) |
| Congenital/neonatal pneumonia | Clinical | Occasional | Verify pneumonia term |
| Neonatal respiratory distress | Clinical | Frequent in preterm | HP:0002098 Respiratory distress |
| Bronchopulmonary dysplasia | Clinical | Increased odds; effect modified by postnatal exposures | Verify — HPO BPD term |
| Necrotizing enterocolitis | Clinical | Increased odds | Verify |
| Intraventricular hemorrhage | Clinical | Increased odds | Verify |
| Cystic periventricular leukomalacia | Radiologic/pathologic | RR 3.0 (clinical CA), RR 2.1 (histologic CA) | Verify PVL term |
| Cerebral palsy | Clinical, long-term | RR 1.9 preterm (clinical CA); RR 4.7 term | HP:0100021 Cerebral palsy (verify) |
| Retinopathy of prematurity | Clinical | Increased odds | Verify |
| Patent ductus arteriosus | Clinical | Increased odds (meta-analysis, PMC4574167) | HP:0001643 Patent ductus arteriosus |
| Elevated cord-blood IL-6 (>11 pg/mL) — FIRS | Lab abnormality | Defines FIRS type I | Model as biochemical, not phenotype |
| Fetal/neonatal death, stillbirth | Clinical | Rare-to-occasional | HP:0001622-adjacent; use Stillbirth term |
Bottom line: there are no causal genes. Chorioamnionitis is not Mendelian, has no OMIM entry, no pathogenic variants, no ClinVar submissions as a monogenic condition, no chromosomal abnormalities, and no genetic testing indication. Anything a deep-research tool tells you about "causal genes for chorioamnionitis" is a hallucination or a Named Entity Confusion event — apply the just preflight-dr logic mentally: MONDO:0000409 records no RO:0004003 causal gene, so a DR preflight would return SKIP, and the manual checks apply.
What does exist is a modest, largely non-replicated susceptibility-variant literature. Curate these with relationship_type: SUSCEPTIBILITY and inheritance_term: HP:0010982 (polygenic) only if you can quote a real abstract; otherwise leave the genetic: block empty.
| Gene | HGNC | Variant | Reported association | Evidence quality |
|---|---|---|---|---|
| TNF | hgnc:11892 | −308 G>A (TNF-2, rs1800629) | SPTB OR 2.7; BV interaction OR 6.1 (PMID:15284722) | Contested — null meta-analyses |
| TNF | hgnc:11892 | −863 C>A (rs1800630) | Adverse outcomes after preterm labor (PMID:15507966) | Single study |
| IL6 | hgnc:6018 | −174 G>C (rs1800795) | Preterm birth / histologic chorioamnionitis | Inconsistent |
| IL1RN | hgnc:6000 | VNTR allele 2 | Preterm birth, intra-amniotic inflammation | Inconsistent |
| TLR4 | hgnc:11850 | Asp299Gly (rs4986790) | Reduced LPS responsiveness; altered risk | Inconsistent |
| IL10 | hgnc:5962 | −1082, −819, −592 haplotypes | Histologic chorioamnionitis (Caucasoid case-control, PMC554771) | Single study |
| MBL2 | hgnc:6922 | Low-producing haplotypes | Increased infection susceptibility | Weak |
| SERPINH1, COL4A3, MMP9, MMP1 | — | Promoter variants | PPROM susceptibility, some ancestry-specific | Weak |
A useful HuGE review of preterm-birth genetics exists (Genetic variation associated with preterm birth: A HuGE review, Genet Med) — treat it as the umbrella citation for "many candidate genes, little replication."
Epigenetics. Emerging and thin. Reported: differential placental DNA methylation in histologic chorioamnionitis; cord-blood methylation signatures of intrauterine inflammation; histone-modification-mediated priming of the fetal innate immune compartment (trained immunity) after in-utero LPS/Ureaplasma exposure in animal models. No validated epigenetic biomarker exists. Curate as KNOWLEDGE_GAP.
Chromosomal abnormalities: none. Somatic variation: not applicable. Modifier genes: not established.
Cigarette smoking (↑ risk, and ↑ PPROM); alcohol use (↑ risk, listed among StatPearls risk factors); illicit drug use; obesity/high BMI; poor periodontal health (periodontitis → oral organisms in amniotic fluid, notably F. nucleatum); nutritional deficiency; sexual activity and vaginal douching (via microbiome disruption); short interpregnancy interval.
| Organism | NCBITaxon | Role |
|---|---|---|
| Ureaplasma parvum | NCBITaxon:134821 | Most common single isolate; low-grade chronic inflammation |
| Ureaplasma urealyticum | NCBITaxon:2130 | Robust host response despite "low virulence" reputation |
| Mycoplasma hominis | NCBITaxon:2098 | Frequent co-isolate |
| Streptococcus agalactiae (GBS) | NCBITaxon:1311 | Major cause of early-onset neonatal sepsis |
| Escherichia coli | NCBITaxon:562 | Major cause of EOS in preterm |
| Fusobacterium nucleatum | NCBITaxon:851 | Oral-origin; hematogenous seeding; causes stillbirth in mice |
| Gardnerella vaginalis | NCBITaxon:2702 | BV-associated |
| Sneathia sanguinegens | NCBITaxon:40543 | Uncultivable; 16S-detected |
| Bacteroides spp. | NCBITaxon:816 | Anaerobic |
| Candida albicans | NCBITaxon:5476 | Cerclage/IUD-associated; severe outcomes |
| Listeria monocytogenes | NCBITaxon:1639 | Hematogenous route |
| Trichomonas vaginalis | NCBITaxon:5722 | Risk factor via BV-like dysbiosis |
On Ureaplasma specifically — the "commensal" framing is wrong:
"Patients with preterm premature rupture of membranes and microbial invasion of the amniotic cavity with U urealyticum are associated with a robust host inflammatory response in the fetal, amniotic, and maternal compartments."
[VERBATIM]— Yoon BH, Romero R, et al. Am J Obstet Gynecol 1998;179(5):1254-60 (PMID:9822511). In that series, histologic chorioamnionitis was present in 100% (22/22) of U. urealyticum-positive cases vs 42% (30/72) of culture-negative cases.
Here's the causal chain, told as one continuous story, then decomposed into pathograph nodes.
A shift in the vaginal microbiome (loss of Lactobacillus dominance, rise of BV-associated anaerobes) removes the chemical fence at the cervix. Organisms — or, in the sterile route, host debris and stress signals from stretched, aging membranes — reach the choriodecidual interface. There, pattern-recognition receptors on decidual stromal cells, chorionic trophoblast, amnion epithelium, and resident macrophages read the signal: TLR4 for Gram-negative LPS, TLR2/TLR6 for lipoproteins and mycoplasmal lipoproteins, TLR9 for bacterial CpG DNA, and RAGE/TLR4 for the alarmin HMGB1 in the sterile arm. Both microbial PAMPs and sterile DAMPs converge on the same receptor plumbing — which is exactly why sterile and microbial intra-amniotic inflammation produce indistinguishable placental pathology and comparably bad neonatal outcomes.
Receptor engagement activates MyD88 → IRAK → TRAF6 → IKK → NF-κB and, in parallel, the MAPK cascades. NF-κB drives transcription of IL-1β, IL-6, IL-8/CXCL8, TNF-α, CCL2, and the NLRP3 inflammasome components. Assembled NLRP3 inflammasome → caspase-1 → mature IL-1β and IL-18, plus gasdermin-D-mediated pyroptosis of amnion and decidual cells — this is the amplification step that turns a signal into a syndrome.
Three downstream output arms then run in parallel:
Meanwhile, the fetus mounts its own systemic response. Fetal plasma IL-6 rises, defining FIRS:
"A systemic fetal inflammatory response, as determined by an elevated fetal plasma interleukin-6 value, is an independent risk factor for the occurrence of severe neonatal morbidity."
[VERBATIM — conclusion sentence]— Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. Am J Obstet Gynecol 1998;179(1):194-202 (PMID:9704787).
FIRS is multi-organ. In the lung, aspirated infected fluid plus cytokines cause fetal pneumonitis and paradoxical "inflammatory lung maturation" (surfactant up, alveolarization and microvascular development down) → the arrested-development phenotype of BPD. In the brain, circulating IL-1β/IL-6/TNF-α plus systemic hypotension activate microglia; pre-oligodendrocytes — exquisitely vulnerable at 23–32 weeks — die by oxidative and excitotoxic injury; myelination fails → periventricular leukomalacia and later cerebral palsy. In the gut, inflammatory priming plus impaired mesenteric perfusion predisposes to NEC. In the eye, altered IGF-1/VEGF signaling contributes to ROP. In the heart/vasculature, cytokines impair ductal closure → PDA. The thymus involutes.
There are two immunologically distinct flavors of FIRS:
FIRS Type I shows "upregulation of host immune responses, including neutrophil and monocyte functions, together with a proinflammatory cytokine storm"; FIRS Type II shows "a mild chronic inflammatory response involving perturbation of HLA transcripts, suggestive of fetal semiallograft rejection."
[PARAPHRASE — reverify]— Para R, Romero R, Miller D, et al. ImmunoHorizons 2021;5(9):735-751 (PMID:34521696). Type I is defined by cord IL-6 >11 pg/mL + acute funisitis; Type II by cord CXCL10 >82.34 pg/mL + chronic placental inflammation + cord IL-6 <11 pg/mL. Only Type I belongs on this entry; Type II belongs with chronic chorioamnionitis / villitis of unknown etiology.
| Node | biological_scale |
Key content |
|---|---|---|
| Vaginal Microbiome Dysbiosis and Cervical Barrier Breach | ORGANISM | BV, loss of Lactobacillus; trigger node |
| Ascending Microbial Invasion of the Choriodecidual Space | TISSUE | Stage II; deciduitis |
| Pattern Recognition Receptor Activation (TLR4/TLR2) | MOLECULAR | GO:0002224; PAMP and DAMP convergence |
| Alarmin Release and Sterile Inflammatory Signaling | MOLECULAR | HMGB1/RAGE; the sterile arm |
| NF-κB-Driven Proinflammatory Cytokine Production | CELLULAR | IL-1β, IL-6, TNF-α, CXCL8 |
| NLRP3 Inflammasome Activation and Pyroptosis | CELLULAR | Caspase-1, mature IL-1β, GSDMD |
| Chemokine Gradient Formation and Neutrophil Chemotaxis | CELLULAR | GO:0030593 |
| Maternal Inflammatory Response (Acute Chorioamnionitis) | TISSUE | Maternal neutrophils in chorion/amnion |
| Fetal Inflammatory Response (Funisitis / Chorionic Vasculitis) | TISSUE | Fetal neutrophils in cord/chorionic vessels |
| Prostaglandin Synthesis and Myometrial Activation | MOLECULAR | PTGS2 ↑, HPGD ↓, GJA1 ↑ |
| MMP-Mediated Extracellular Matrix Degradation | MOLECULAR | MMP-8/MMP-9; TIMP ↓ |
| Membrane Weakening and Preterm Prelabor Rupture | TISSUE | PPROM |
| Preterm Labor and Birth | ORGANISM | |
| Fetal Inflammatory Response Syndrome (FIRS Type I) | ORGANISM | Cord IL-6 >11 pg/mL |
| Fetal Pulmonary Inflammation and Arrested Alveolarization | TISSUE | → BPD |
| Microglial Activation and Pre-Oligodendrocyte Injury | CELLULAR | → PVL, CP |
| Reduced Myometrial Contractility (Maternal, Term) | TISSUE | → dysfunctional labor, atony, PPH |
| Early-Onset Neonatal Sepsis | ORGANISM |
Note the elegant/annoying duality worth flagging as a mechanistic_hypotheses pair: the same inflammatory mediator load that drives preterm labor also impairs term myometrial contractility (→ cesarean and postpartum hemorrhage). Curate as two hypothesis groups (preterm_uterotonic_activation vs term_myometrial_suppression) rather than as a single contradictory edge — the mechanisms differ by gestational age and receptor context (PMID:29848185).
[VERBATIM] — Garcia-Flores V, Romero R, Tarca AL, et al. Sci Transl Med 2024;16(729):eadh8335 (PMID:38198568). Companion resources: single-cell atlas of murine reproductive tissues during preterm labor (Cell Rep 2022); single-cell transcriptional signatures of the human placenta in term and preterm parturition (eLife 2019, Pique-Regi et al.).Primary (maternal-fetal interface): - Chorion — UBERON:0003124 (verify) - Amnion — UBERON:0000305 (verify) - Chorioamniotic (extraembryonic/fetal) membranes — verify best UBERON parent, possibly UBERON:0000478 extraembryonic structure - Decidua — UBERON:0002450 (verify) - Placenta — UBERON:0001987 (verify) - Amniotic fluid — UBERON:0000173 (verify) - Umbilical cord (incl. Wharton's jelly) — UBERON:0002331 (verify) - Uterus / myometrium — UBERON:0000995 / UBERON:0001296 (verify) - Uterine cervix — UBERON:0000002 (verify) - Vagina — UBERON:0000996 (verify)
Secondary (fetal/neonatal end-organ): lung (UBERON:0002048), brain — specifically periventricular white matter and germinal matrix (UBERON:0002316 white matter, verify), intestine (UBERON:0000160), eye/retina (UBERON:0000970 / UBERON:0000966), heart/ductus arteriosus (UBERON:0001496 verify), thymus (UBERON:0002370).
Body systems: reproductive, immune, respiratory, nervous, digestive, cardiovascular.
Tissue types: amniotic squamous/cuboidal epithelium; chorionic trophoblast; decidual and chorionic connective/stromal tissue; myometrial smooth muscle; umbilical vascular endothelium and smooth muscle; Wharton's jelly (specialized mucous connective tissue).
Cell populations (Cell Ontology candidates): - neutrophil — CL:0000775 (the defining cell of the lesion) - macrophage — CL:0000235; Hofbauer cell (fetal placental macrophage) — verify - decidual stromal cell — verify CL term - trophoblast cell — CL:0000351 - amnion epithelial cell — verify - fibroblast / stromal cell — CL:0000057 / CL:0000499 - T cell — CL:0000084; regulatory T cell — CL:0000815 (depleted/skewed by Ureaplasma) - natural killer cell — CL:0000623 (decidual NK) - endothelial cell of umbilical vein — verify (HUVEC-adjacent) - microglial cell — CL:0000129 (verify) — fetal brain injury arm - oligodendrocyte precursor / pre-oligodendrocyte — verify — the vulnerable target in PVL - uterine smooth muscle cell — CL:0002601 (verify)
Subcellular (GO Cellular Component): NLRP3 inflammasome complex (GO:0072559, verify); plasma membrane TLR complexes; endosome (TLR9 signaling); nucleus (NF-κB translocation); extracellular region/matrix (GO:0031012); neutrophil azurophil/specific granules (verify); mitochondrion (ROS, mtDNA release as a DAMP).
Localization / lateralization: the ascending lesion is characteristically most severe at the lower uterine pole / membrane rupture site and around the cervical os, tapering toward the placental disc — this gradient is itself diagnostic of the ascending route. Not lateralized in the left/right sense. Funisitis affects the umbilical vein first (phlebitis), then arteries (arteritis), which is a stageable temporal marker.
Onset. Congenital/gestational by definition. Antepartum in the PPROM/preterm-labor route; intrapartum in the term route. Onset pattern is acute to subacute (hours to days), though a low-grade Ureaplasma colonization can smolder for weeks — the "very chronic ureaplasma colonization" of the fetal sheep model.
Stages. Use the two complementary staging systems:
Romero clinical/microbiological staging (ascending route) — Stage I cervicovaginal dysbiosis → Stage II choriodeciduitis → Stage III intra-amniotic infection (amnionitis, choriovasculitis) → Stage IV fetal infection.
Amsterdam consensus histologic staging (Khong TY, Mooney EE, Ariel I, et al., Arch Pathol Lab Med 2016;140(7):698-713, PMID:27223167) — two axes:
Amsterdam recognizes "only stages 2–3 to represent a fully developed histological chorioamnionitis, with stage 1 being a sensitive but less specific indicator" — an important curation nuance, since much of the older literature counts Stage 1 as positive and therefore reports inflated prevalences.
Progression rate. Rapid once intra-amniotic invasion occurs. Untreated, the interval from intra-amniotic infection to delivery is typically short (days); severity of neonatal outcome tracks both organism and duration of exposure. Progression from chorio-deciduitis to chorio-deciduo-amnionitis is measurable in days (PMID:26574743).
Course. Maternal: acute, self-limited, resolving with delivery + antibiotics. Fetal/neonatal: acute illness followed by either recovery or a progressive/static-disability course (BPD improving over years; CP static but with evolving functional consequences).
Remission. Maternal remission is treatment-induced and near-universal with delivery + antibiotics. Notably, intra-amniotic infection can be eradicated with antibiotics without delivering in a subset — see §12.
Critical periods. - 23–32 weeks — the pre-oligodendrocyte vulnerability window for white-matter injury; also the canalicular/saccular lung window where inflammation arrests alveolarization. - Latency period after PPROM — the intervention window for latency antibiotics + antenatal corticosteroids + magnesium sulfate. - ≥18 hours ROM — the inflection point for infection risk and for GBS prophylaxis indication. - Intrapartum, first 4 hours of fever — the window in which myometrial contractility declines (~2 hours post-fever onset), driving the cesarean/atony risk.
| Measure | Value | Source/notes |
|---|---|---|
| Clinical chorioamnionitis, all births (US) | 1–5% (commonly quoted 1–4%) | Definition-dependent |
| Clinical chorioamnionitis, national US administrative data | 1.29% of >9 million live births | Recent national analysis |
| Secular trend | 2.7% (1995–96) → 6.0% (2009–10) | Kaiser Permanente Southern California; rate more than doubled |
| Clinical chorioamnionitis at term | ~2–5% of term deliveries | |
| Histologic acute chorioamnionitis at term | 3–5% | Kim 2015 (PMID:26428501) |
| Histologic acute chorioamnionitis at 21–24 weeks | 94% | Kim 2015 — the key gradient |
| Histologic chorioamnionitis in PPROM | ~24% in one series (72/295); higher in others | PMC10079121 |
| Intrauterine infection as cause of preterm birth | ~25–40% of all preterm births; up to 40–70% of early preterm | Goldenberg RL, Hauth JC, Andrews WW. N Engl J Med 2000;342(20):1500-7 (PMID:10816189 — no abstract available, cite as review) |
| Microbial invasion of amniotic cavity in preterm labor | ~35%, of which ~28% Ureaplasma | |
| Sterile intra-amniotic inflammation in preterm labor, intact membranes | 26% vs 11% microbial-associated | PMID:25078709 |
Incidence expressed per 100,000 for the dismech Prevalence block: clinical chorioamnionitis ≈ 1,290–5,000 per 100,000 live births (measure_type: BIRTH_PREVALENCE, prevalence_class: ABOVE_1_IN_1000, rate_per_100000: 1290 for the national-administrative estimate; add a second record for the histologic lesion at term, ~3,000–5,000/100,000, and a third for the 21–24-week stratum at ~94,000/100,000 which is the striking one). Use population: for the cohort and put the verbatim source phrasing in notes:.
Not applicable as a Mendelian trait. If an inheritance: block is curated at all, it should be HP:0010982 Polygenic inheritance with relationship_type: SUSCEPTIBILITY on the contributing genes, and the block description must state plainly that the condition is acquired and infectious/inflammatory with only modest, unreplicated host-genetic modification. There is no penetrance, expressivity, anticipation, germline mosaicism, founder effect, consanguinity role, or carrier frequency to curate. Do not invent these.
As in §1: NICHD Triple I tiers (isolated fever / suspected / confirmed) and ACOG CO 712 thresholds. The clinical diagnosis is sensitive but poorly specific — the central diagnostic problem of this disease.
Maternal blood: CBC with differential (WBC >15,000/mm³, left shift; confounded by corticosteroids and by labor itself), CRP, procalcitonin (better specificity than CRP for true infection), blood cultures (positive in a minority), lactate if sepsis suspected.
Amniotic fluid (via amniocentesis — the reference standard, but invasive and rarely performed at term):
| Test | Threshold | Performance |
|---|---|---|
| Gram stain | Any organisms | Highly specific, poorly sensitive (misses mycoplasmas entirely — no cell wall) |
| Glucose | <14–15 mg/dL | Mean 5 ± 2.4 mg/dL in IAI vs 39.8 ± 18.4 mg/dL without; "more sensitive and more specific than Gram's stain" |
| WBC count | >50 cells/mm³ | Moderate |
| LDH | Elevated; isoform mapping | Research-grade |
| IL-6 | ≥2.6 ng/mL (Romero) or ≥11.3 ng/mL depending on assay | Sens 88%, spec 70%, PPV 67%, NPV 89% |
| MMP-8 | Rapid point-of-care strip | Sens 80%, spec 87%, PPV 81%, NPV 86% |
| Culture (aerobic + anaerobic + mycoplasma-specific) | Growth | Definitive but slow and insensitive |
| Broad-range PCR / PCR-ESI-MS, 16S rRNA sequencing | Detection | Detects uncultivable organisms; the modern reference |
An important curation point: AF IL-6/MMP-8 define inflammation; culture/PCR define infection. The 2×2 of these two axes (microbial-associated inflammation / sterile inflammation / colonization without inflammation / neither) is the correct mechanistic taxonomy and should shape the definitions[] and biochemical blocks.
Fetal/neonatal: cord-blood IL-6 (>11 pg/mL defines FIRS type I), cord CXCL10 (>82.34 pg/mL, FIRS type II), neonatal CBC with I:T ratio, CRP, procalcitonin, blood culture, CSF if indicated, gastric aspirate/surface cultures (low yield, largely abandoned).
LOINC anchors (verify all): serum glucose, WBC count, CRP, procalcitonin, IL-6, and the amniotic-fluid analyte codes. Given your loinc-no-reference-ranges memory, do not attempt to source reference intervals from LOINC — cite the primary literature intervals above and put non-citable lab-manual provenance in notes:.
Placental examination per Amsterdam criteria: staged and graded MIR and FIR as in §8. Immunohistochemistry (CD15, myeloperoxidase) can help distinguish maternal vs. fetal neutrophils in ambiguous cases; XY-FISH or HLA-typing definitively assigns neutrophil origin in research settings. Necrotizing funisitis implies chronic (days-to-weeks) fetal inflammation and carries the worst neurodevelopmental prognosis.
None indicated. Not applicable: WGS, WES, gene panels, single-gene testing, CMA, karyotype, FISH, mtDNA testing, repeat-expansion testing. This is worth stating explicitly in the entry so downstream tools don't infer absence-of-evidence.
| Alternative | Distinguishing features |
|---|---|
| Epidural-related maternal fever | Fever after epidural placement, no purulent discharge, WBC often normal-ish, IL-6 elevated but AF sterile, no fetal tachycardia in many cases, antibiotics don't help |
| Urinary tract infection / pyelonephritis | CVA tenderness, pyuria, positive urine culture |
| Influenza, COVID-19, other systemic viral illness | Respiratory symptoms, seasonality, viral testing |
| Appendicitis | RLQ/migrating pain, peritoneal signs, leukocytosis without genital findings |
| Placental abruption | Vaginal bleeding, uterine hypertonus, non-reassuring FHR, no fever |
| Dehydration/environmental hyperthermia | Responds to hydration/cooling |
| Drug fever, transfusion reaction | Temporal association |
| Thyroid storm | Rare; thyrotoxic features |
| Chronic chorioamnionitis / villitis of unknown etiology | Lymphocytic, not neutrophilic; late preterm; maternal anti-fetal rejection biology |
| Post-partum endometritis | Onset after delivery |
[VERBATIM] — ACOG CO 712 (PMID:28742677). Add: cesarean delivery (2–3× increased), wound infection, pelvic abscess, septic pelvic thrombophlebitis, necrotizing fasciitis (rare), blood transfusion, prolonged hospitalization.[VERBATIM] — ACOG CO 712.Pooled effect sizes worth curating (each needs its own PMID + verified snippet): - Early-onset sepsis: combined OR 3.45 (95% CI 2.02–5.89) for chorioamnionitis overall in preterm infants; histologic chorioamnionitis unadjusted pooled OR 4.42 (2.68–7.29) for confirmed EOS and 5.88 (3.68–9.41) for any EOS (Frontiers in Immunology 2020 systematic review/meta-analysis/meta-regression, PMC7289970). - Composite adverse neonatal outcomes: approximately 2- to 3.5-fold increased odds of perinatal death, EOS, septic shock, pneumonia, meningitis, IVH, cerebral white-matter damage, ROP, NEC, and long-term disability including CP. - PDA: significant association on meta-analysis (PMC4574167). - Funisitis specifically carries worse short-term prematurity outcomes than chorioamnionitis alone (frequentist + Bayesian meta-analysis, PMID:36830092).
"Using a random effects model, clinical chorioamnionitis was significantly associated with both cerebral palsy (RR, 1.9; 95% CI, 1.4-2.5) and cPVL (RR, 3.0; 95% CI, 2.2-4.0) in preterm infants. The RR of histologic chorioamnionitis and cerebral palsy was 1.6 (95% CI, 0.9-2.7) in preterm infants, and histologic chorioamnionitis was significantly associated with cPVL (RR, 2.1; 95% CI, 1.5-2.9). Among full-term infants, a positive association was found between clinical chorioamnionitis and cerebral palsy (RR, 4.7; 95% CI, 1.3-16.2)."
[VERBATIM]— Wu YW, Colford JM Jr. JAMA 2000;284(11):1417-1424 (PMID:10989405).
Additional long-term: bronchopulmonary dysplasia and childhood respiratory morbidity/asthma; neurodevelopmental impairment and lower cognitive scores; increased long-term infectious morbidity of offspring (PMID:38337508); associations with autism spectrum disorder and schizophrenia in the broader maternal-immune-activation literature (weaker, confounded — curate as EMERGING with a KNOWLEDGE_GAP).
Gestational age at exposure (dominant); presence and stage of funisitis (fetal, not just maternal, response — much stronger predictor); cord IL-6 >11 pg/mL (FIRS); necrotizing funisitis (worst); organism identity (Candida, GBS, E. coli worse than Ureaplasma alone for acute sepsis; Ureaplasma disproportionately associated with BPD); duration of ROM; maternal antibiotic administration; antenatal corticosteroid exposure; birthweight; male sex; presence of chronic vs acute inflammation.
Prognostic biomarkers: cord-blood IL-6, CXCL10; AF MMP-8 and IL-6; neonatal CRP/procalcitonin trajectory; the AF proteomic MR score.
Per ACOG CO 712 (PMID:28742677): "Administration of intrapartum antibiotics is recommended whenever an intraamniotic infection is suspected or confirmed."
| Regimen | Detail | NCIT anchor |
|---|---|---|
| Ampicillin + gentamicin (first line) | Ampicillin 2 g IV q6h + gentamicin 2 mg/kg load then 1.5 mg/kg q8h (or 5 mg/kg q24h) | Pharmacotherapy NCIT:C15986 + therapeutic_agent ampicillin (CHEBI:28971 verify), gentamicin (CHEBI — verify) |
| Add clindamycin or metronidazole for cesarean delivery | Anaerobic coverage at cord clamp | + clindamycin (CHEBI:3745 verify) / metronidazole (CHEBI:6909 verify) |
| Penicillin-allergic (mild) | Cefazolin + gentamicin | |
| Penicillin-allergic (severe) | Clindamycin or vancomycin + gentamicin | |
| Duration | Through delivery; "Antibiotic therapy should only be continued postdelivery in women with risk factors for postpartum endometritis, such as bacteremia or persistent fever" [VERBATIM] |
Adjuncts: antipyretics (acetaminophen — CHEBI:46195, verify) — reduces maternal and fetal tachycardia and may reduce unnecessary intervention; delivery is the definitive therapy for the maternal disease (but not an automatic indication for cesarean); IV hydration; oxytocin augmentation with anticipation of atony; active management of the third stage.
Modality tags: therapeutic_modality: SMALL_MOLECULE for the antibiotics, SURGERY for cesarean, SUPPORTIVE→ use NCIT:C15747 Supportive Care with BEHAVIORAL/OTHER as appropriate.
WRONG_STATEMENT/harm-of-treatment evidence item.[VERBATIM] — Lee J, Romero R, Kim SM, Chaemsaithong P, Yoon BH. J Matern Fetal Neonatal Med 2016;29(17):2727-37 (PMID:26441216). In preterm labor with intact membranes, eradication was confirmed in 79% of those with follow-up amniocentesis (PMID:30928566). This is a genuinely under-appreciated therapeutic finding and deserves an EMERGING hypothesis node — the field's default is "infection means deliver," and these data say a subset can be treated.[PARAPHRASE — reverify]Gene therapy, cell therapy, RNA-based therapies, targeted small-molecule oncology-style therapies, immunotherapies (checkpoint inhibitors), rehabilitation for the acute maternal illness. Rehabilitation IS relevant downstream for CP-affected offspring (physical therapy NCIT:C15302, occupational therapy NCIT:C121351, speech therapy NCIT:C159273) — curate those on the sequelae, not on chorioamnionitis itself.
Search ClinicalTrials.gov for: NCT registrations on azithromycin vs erythromycin for PPROM (e.g., NCT07183462 for late PPROM), intra-amniotic infection eradication regimens, antenatal N-acetylcysteine for inflammation-associated fetal brain injury, IL-1 receptor antagonist (anakinra) and the small-molecule IL-1R antagonist rytvela (101.10) for intrauterine inflammation (preclinical→early clinical), TLR4 antagonists, and probiotic/vaginal-microbiome-modulation trials. Populate clinical_trials: with just fetch-reference NCT… — do not hand-write these, and remember phase is an enum (PHASE_III, not "Phase III").
No established PGx for this indication. Relevant general PGx: aminoglycoside ototoxicity and MT-RNR1 m.1555A>G (CPIC guideline — a genuine, curatable, actionable gene-drug pair given that gentamicin is first-line therapy here). That's the one PGx item worth including, and it's a nice one because it's real, actionable, and specific to the standard regimen.
Primary prevention - Universal antenatal GBS screening at 36 0/7–37 6/7 weeks with intrapartum penicillin prophylaxis for colonized women, ROM ≥18 h, prior GBS-affected infant, GBS bacteriuria, or intrapartum fever with unknown status. Reduced early-onset GBS disease from 1.8 → 0.23 per 1,000 live births. - Minimize digital cervical examinations, especially after ROM; prefer sterile speculum; avoid unnecessary internal monitoring. - Avoid/limit unnecessary labor induction and prolonged latent-phase management where clinically reasonable. - Treat symptomatic bacterial vaginosis, trichomoniasis, gonorrhea, chlamydia; treat asymptomatic bacteriuria. - Periodontal care in pregnancy (mechanistically motivated by F. nucleatum; randomized trials of periodontal treatment have not reduced preterm birth — curate the mechanism as plausible and the intervention as ineffective, which is a nice honest pairing). - Smoking cessation, weight management, adequate interpregnancy interval. - Aseptic technique for amniocentesis/CVS/cerclage; timely removal of retained IUD. - Vaginal cleansing before cesarean; adjunctive azithromycin at unscheduled cesarean.
Secondary prevention - Early recognition of PPROM; latency antibiotics; serial monitoring for infection (temperature, WBC, FHR, fetal movement). - Amniocentesis for AF IL-6/MMP-8/culture in selected PPROM and preterm-labor cases → antibiotic eradication attempt. - Cervical-length screening + vaginal progesterone / cerclage in the appropriate high-risk groups (prevents preterm birth, and by extension exposure). - Serial GBS-status verification; prompt intrapartum prophylaxis.
Tertiary prevention - Antenatal corticosteroids; magnesium sulfate for neuroprotection <32 weeks. - Delivery timing decisions balancing infection against prematurity. - Risk-stratified neonatal EOS evaluation (avoiding iatrogenic harm from over-treatment — antibiotic exposure in the first week is itself associated with NEC, late-onset sepsis, and microbiome disruption). - Neurodevelopmental follow-up programs for exposed preterm infants.
Immunization. No licensed vaccine prevents chorioamnionitis. Maternal GBS conjugate/protein vaccines are in advanced clinical development (Pfizer hexavalent GBS6, MinervaX) and are the most plausible future primary-prevention tool; WHO has published preferred product characteristics. Influenza and Tdap vaccination in pregnancy are unrelated to this pathway. Curate GBS vaccines as EXPERIMENTAL with therapeutic_modality: VACCINE, NCIT:C15346 vaccination.
Genetic counseling / genetic screening / PGD / prenatal genetic testing: not applicable. State this explicitly.
Public health interventions: antenatal care access and coverage; STI screening and partner treatment programs; skilled birth attendance and clean-delivery practices (WHO); antimicrobial stewardship in obstetrics and neonatology; hand hygiene and infection-control bundles on labor and delivery.
Chorioamnionitis and its cousin, placentitis, are genuinely important in veterinary medicine — this isn't a courtesy section.
| Species | NCBITaxon | Natural disease |
|---|---|---|
| Horse (Equus caballus) | NCBITaxon:9796 | Placentitis is a leading cause of abortion, premature birth, and weak foals. Two forms: (a) ascending bacterial placentitis (Streptococcus equi subsp. zooepidemicus, E. coli, Leptospira, Klebsiella) with cervical-star lesions; (b) nocardioform placentitis — focal mucoid lesions on the ventral uterine body/horn bases, 85% caused by Amycolatopsis spp. and Crossiella equi, gram-positive branching actinomycetes; episodic outbreaks, mechanism still poorly understood. Transcriptomic analysis of equine chorioallantois in nocardioform placentitis has mapped the immune networks involved (Vet Res 2021). |
| Cattle (Bos taurus) | NCBITaxon:9913 | Ureaplasma diversum causes placentitis, fetal alveolitis, abortion and weak calves, mainly in the last trimester. Its membrane-associated lipoproteins activate inflammatory genes through the NF-κB pathway via TLR4 (PMC6052353) — a direct mechanistic homolog of the human Ureaplasma story. Also Brucella abortus, Coxiella burnetii, Campylobacter fetus, Tritrichomonas foetus, Chlamydia, BVDV. |
| Sheep (Ovis aries) | NCBITaxon:9940 | Chlamydia abortus (enzootic abortion of ewes) and Coxiella burnetii — both zoonotic, causing severe disease including chorioamnionitis and pregnancy loss in exposed pregnant humans. The sheep is also the experimental model (see §15). |
| Goat (Capra hircus) | NCBITaxon:9925 | C. abortus, C. burnetii |
| Pig (Sus scrofa) | NCBITaxon:9823 | Leptospira, Brucella suis, PRRSV-associated placentitis |
| Dog / Cat | NCBITaxon:9615 / 9685 | Brucella canis, E. coli, Streptococcus placentitis; feline herpesvirus, FIV/FeLV-associated losses |
| Rhesus macaque (Macaca mulatta) | NCBITaxon:9544 | Naturally occurring chorioamnionitis reported in colonies; also the premier experimental model |
Comparative pathology. The neutrophilic ascending-infection pattern is broadly conserved across placental mammals, but placental architecture is not — humans and NHPs are hemochorial and discoid; ruminants are epitheliochorial/cotyledonary; horses are diffuse epitheliochorial. This is the single most important caveat for cross-species extrapolation and belongs in a HUMAN_MODEL_MISMATCH discussion: an epitheliochorial placenta has more physical layers between maternal blood and fetus, which changes both microbial access and cytokine transfer. Sheep, the workhorse fetal-physiology model, are exactly the mismatch case.
Evolutionary conservation. TLR4/MyD88/NF-κB signaling, IL-1/IL-6/TNF, the NLRP3 inflammasome, MMP-8/MMP-9, and prostaglandin synthesis are deeply conserved across mammals (Alliance of Genome Resources / HomoloGene orthologs exist for all of these). The timing control of parturition, by contrast, is poorly conserved — mice depend on luteolysis/progesterone withdrawal, humans do not — which limits mouse preterm-labor models specifically.
Zoonotic potential / cross-species transmission. Real and clinically important: Coxiella burnetii (Q fever) and Chlamydia abortus from parturient small ruminants cause human placentitis, chorioamnionitis and pregnancy loss; Brucella spp.; Listeria monocytogenes (foodborne, from animal reservoirs); Toxoplasma gondii (felid definitive host). Pregnant people are specifically counseled to avoid lambing/kidding operations — a real public-health rule grounded in this mechanism.
Orthologous genes for the mechanism nodes: mouse Tlr4 (NCBI Gene 21898), Il6 (16193), Il1b (16176), Tnf (21926), Nlrp3 (216799), Ptgs2 (19225), Mmp9 (17395) — verify all IDs before curating.
Chorioamnionitis has an unusually good and unusually large-animal-weighted model landscape, because the key readouts (fetal lung, fetal brain, chronic instrumentation) need a big fetus.
The gold standard: hemochorial discoid placenta, similar gestational immunology, chronic catheterization possible.
- Intra-amniotic U. parvum: "U. parvum decreased regulatory T cells (Tregs) and activated interferon γ production in these Tregs in the fetus", with organism thriving in AF and colonizing fetal lung but only modest inflammation and no severe chorioamnionitis, plus increased uterine connexin-43 (PMID:27601620*, J Infect Dis 2016;214(10):1597-1604). [PARAPHRASE for the framing sentences — the quoted clause appears verbatim; reverify.]
- Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques (Novy MJ, Grigsby PL et al., Reprod Sci 2009) — the definitive Koch's-postulate-style demonstration for genital mycoplasmas.
- Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques (PMC5011884) — the cleanest primate link from intra-amniotic inflammation to fetal brain injury.
- Intra-amniotic IL-1β → decidual neutrophil recruitment and activation (PMC4342792) — isolates the cytokine arm from the microbe.
- TLR4 antagonist pretreatment inhibited LPS-induced preterm uterine contractility, cytokines and prostaglandins in rhesus monkeys (PMC2774271*) — a genuine mechanistic intervention study and the best evidence for TLR4 as a druggable node.
Rabbit intracervical E. coli inoculation is a classic ascending-infection model (Fidel/Gibbs). Rat and guinea-pig LPS models are used for fetal brain injury; guinea pigs have the advantage of a more human-like brain-growth trajectory.
| Feature | NHP | Sheep | Mouse | Explant/chip |
|---|---|---|---|---|
| Ascending route | ✔✔ | ✔ | ✔ (intrauterine) | ✔ (FMi-OOC) |
| Histologic chorioamnionitis | ✔✔ | ✔✔ | ✔ | n/a |
| Funisitis / FIRS | ✔✔ | ✔ | limited | n/a |
| Preterm labor | ✔✔ | ✔ | ✔✔ | n/a |
| Fetal lung injury/BPD-like | ✔ | ✔✔ | ✔ | n/a |
| Fetal brain injury/PVL-like | ✔ | ✔ | ✔✔ | n/a |
| Genetic tractability | ✘ | ✘ | ✔✔ | ✔ |
| Cost/throughput | ✘ | ~ | ✔✔ | ✔✔ |
Model databases: MGI, IMPC, KOMP/EuMMCR, IMSR, MMRRC, RGD, ZFIN (no meaningful zebrafish model here — no placenta), Alliance of Genome Resources, Cellosaurus, ATCC.
Do not paste any of these into YAML without running just validate-terms. Confidence is my honest read, not a substitute for OAK.
MONDO (high confidence): MONDO:0000409 chorioamnionitis.
HPO — high confidence: HP:0001788 Premature rupture of membranes · HP:0001945 Fever · HP:0001649 Tachycardia · HP:0001974 Leukocytosis · HP:0001622 Premature birth · HP:0002098 Respiratory distress · HP:0100806 Sepsis · HP:0001643 Patent ductus arteriosus. HPO — medium, verify: HP:0011227 Elevated circulating C-reactive protein concentration · HP:0100021 Cerebral palsy · HP:0001561/HP:0001562 Polyhydramnios/Oligohydramnios. HPO — needs lookup: fetal tachycardia; periventricular leukomalacia; intraventricular hemorrhage (neonatal); necrotizing enterocolitis; bronchopulmonary dysplasia; retinopathy of prematurity; stillbirth; purulent vaginal discharge. There may be no HPO term for "chorioamnionitis" itself; the entry's identity should hang off MONDO, not HPO.
GO biological process — high confidence: GO:0006954 inflammatory response · GO:0006955 immune response · GO:0030593 neutrophil chemotaxis · GO:0032496 response to lipopolysaccharide · GO:0002224 toll-like receptor signaling pathway · GO:0001516 prostaglandin biosynthetic process · GO:0030198 extracellular matrix organization · GO:0022617 extracellular matrix disassembly · GO:0032611 interleukin-1 beta production · GO:0032635 interleukin-6 production · GO:0032640 tumor necrosis factor production · GO:0050829 defense response to Gram-negative bacterium · GO:0050830 defense response to Gram-positive bacterium · GO:0007567 parturition · GO:0006979 response to oxidative stress.
GO — verify label drift: GO:0007249 (canonical NF-κB signal transduction — label was renamed; your snippet-validator-normalizes-whitespace and MONDO-obsoletion memories apply here too, check live OLS not just the local sqlite).
GO molecular function: GO:0004222 metalloendopeptidase activity.
GO cellular component: GO:0072559 NLRP3 inflammasome complex · GO:0031012 extracellular matrix.
CL — high confidence: CL:0000775 neutrophil · CL:0000235 macrophage · CL:0000351 trophoblast cell · CL:0000084 T cell · CL:0000815 regulatory T cell · CL:0000623 natural killer cell · CL:0000057 fibroblast. CL — needs lookup: decidual stromal cell; amnion epithelial cell; Hofbauer cell; microglial cell; oligodendrocyte precursor cell; uterine smooth muscle cell; endothelial cell of umbilical vein.
UBERON — needs verification across the board: placenta, amnion, chorion, decidua, amniotic fluid, umbilical cord, uterus, myometrium, uterine cervix, vagina, lung, brain white matter, intestine, retina.
CHEBI: CHEBI:16412 lipopolysaccharide (high) · CHEBI:15551 prostaglandin E2 (high) · CHEBI:17234 glucose (high) · CHEBI:46195 paracetamol (high) · ampicillin, gentamicin, clindamycin, azithromycin, erythromycin, metronidazole, ceftriaxone, betamethasone (all verify; per your therapeutic-agent-chebi-only-cache memory, prefer CHEBI over NCIT for therapeutic_agent).
NCIT (treatment actions): NCIT:C15986 Pharmacotherapy · NCIT:C15747 Supportive Care · NCIT:C15329 Surgical Procedure (cesarean — look for a specific cesarean-section term) · NCIT:C15346 Vaccination (GBS vaccine, experimental) · NCIT:C15302 Physical Therapy (downstream CP care).
NCBITaxon: as listed in §5.3 and §14.
A few things that will save time (and reviewer round-trips) when this becomes kb/disorders/Chorioamnionitis.yaml:
mechanistic_hypotheses group, not a footnote. Sterile intra-amniotic inflammation is more common than microbial in preterm labor with intact membranes (26% vs 11%) and produces equivalent outcomes. An entry that treats this as purely infectious would be wrong on its own headline claim, and a reviewer will catch it. Suggested groups: microbial_associated_inflammation (CANONICAL), sterile_alarmin_driven_inflammation (CANONICAL — genuinely co-equal, not "alternative"), epidural_systemic_maternal_inflammation (ALTERNATIVE, term-specific).classifications that also capture the inflammatory/perinatal dimension, and say so in the entry notes rather than silently forcing it into one bucket.intestinal_barrier_dysfunction's insult-agnostic convergence logic — several distinct upstream insults (microbial, sterile/alarmin, epidural-systemic) converging on one downstream inflammatory cascade. This entry is arguably a good seed for a new ascending_mucosal_barrier_infection or sterile_vs_microbial_inflammatory_convergence module later; don't force a conformance declaration now.KNOWLEDGE_GAP discussions worth writing: (1) no validated non-invasive test distinguishes microbial-associated from sterile intra-amniotic inflammation, so antibiotic decisions are made blind; (2) the causal direction between histologic chorioamnionitis and preterm labor is not fully resolved at term, where inflammation may be a consequence of labor rather than its cause.HUMAN_MODEL_MISMATCH discussion: placental architecture differs fundamentally between the sheep/ruminant models (epitheliochorial) and humans (hemochorial), and mouse parturition is progesterone-withdrawal-dependent while human parturition is not — so neither the dominant fetal-physiology model nor the dominant genetics model reproduces the human timing mechanism.MODEL_ORGANISM; the chorioamniotic-membrane explant and cell-line work is IN_VITRO; the amniocentesis cohorts, meta-analyses, and guidelines are HUMAN_CLINICAL. Do not let a macaque or sheep citation be the sole support for a human phenotype node — that's a recurring reviewer finding.[26% (35/135) versus 11% (15/135)), which will pass a local check and then fail CI. Trim those quotes at a bracket-free boundary before committing.Primary literature (PubMed): - Kim CJ, Romero R, et al. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. AJOG 2015;213(4 Suppl):S29-52 — PMID:26428501 - Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. AJOG 1998;179(1):194-202 — PMID:9704787 - Romero R, Miranda J, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation. Am J Reprod Immunol 2014;72(5):458-74 — PMID:25078709 - Higgins RD, Saade G, Polin RA, et al. Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop. Obstet Gynecol 2016;127(3):426-436 — PMID:26855098 - ACOG Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection. Obstet Gynecol 2017;130(2):e95-e101 — PMID:28742677 - Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000;284(11):1417-1424 — PMID:10989405 - Khong TY, Mooney EE, Ariel I, et al. Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med 2016;140(7):698-713 — PMID:27223167 - Jung E, Romero R, Suksai M, et al. Clinical chorioamnionitis at term. AJOG 2024;230(3S):S807-S840 — PMID:38233317 - Yoon BH, Romero R, et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum. AJOG 1998;179(5):1254-60 — PMID:9822511 - Lee J, Romero R, Kim SM, Chaemsaithong P, Yoon BH. A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in preterm PROM. J Matern Fetal Neonatal Med 2016;29(17):2727-37 — PMID:26441216 - Antibiotic administration can eradicate intra-amniotic infection or inflammation in preterm labor with intact membranes — PMID:30928566 - Garcia-Flores V, Romero R, et al. Deciphering maternal-fetal cross-talk in the human placenta during parturition using scRNA-seq. Sci Transl Med 2024;16(729):eadh8335 — PMID:38198568 - Para R, Romero R, et al. The Distinct Immune Nature of the Fetal Inflammatory Response Syndrome Type I and Type II. ImmunoHorizons 2021;5(9):735-751 — PMID:34521696 - Senthamaraikannan P, Presicce P, et al. Intra-amniotic Ureaplasma parvum-Induced Maternal and Fetal Inflammation in Rhesus Macaques. J Infect Dis 2016;214(10):1597-1604 — PMID:27601620 - Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342(20):1500-7 — PMID:10816189 (no abstract) - Macones GA, et al. A polymorphism in the promoter region of TNF and bacterial vaginosis — PMID:15284722 - Adverse outcomes after preterm labor and TNF-alpha polymorphism -863 — PMID:15507966 - Timing of Histologic Progression from Chorio-Deciduitis to Chorio-Deciduo-Amnionitis — PMID:26574743 - Intra-Amniotic Administration of HMGB1 Induces Spontaneous Preterm Labor and Birth — PMID:26781934 - DAMPs in preterm labor and preterm PROM: HMGB1 — PMID:21958433 - Association of epidural-related fever and noninfectious inflammation in term labor — PMID:21343762 - Molecular evidence for hematogenous dissemination of Listeria monocytogenes intraamniotic infection — PMID:40643048 - Utility of Early-Onset Sepsis Risk Calculator for Neonates Born to Mothers with Chorioamnionitis — PMID:29275925 - Association of Funisitis with Short-Term Outcomes of Prematurity: meta-analysis — PMID:36830092 - The Association between Term Chorioamnionitis during Labor and Long-Term Infectious Morbidity of the Offspring — PMID:38337508 - Suspected Chorioamnionitis and Myometrial Contractility — PMID:29848185 - Impact of microbial invasion of amniotic cavity and type of microorganisms on neonatal outcome — PMID:28094842 - Chorioamnionitis caused by Listeria monocytogenes: ultrasound features — PMID:23429225 - Fetal heart rate patterns complicated by chorioamnionitis and subsequent cerebral palsy — PMID:36433630
PMC / journal full text: - Association of Histological and Clinical Chorioamnionitis With Neonatal Sepsis: meta-analysis (Front Immunol 2020) - Uncultivated Bacteria as Etiologic Agents of Intra-Amniotic Inflammation Leading to Preterm Birth (J Clin Microbiol 2008) - HMGB1 Induces an Inflammatory Response in the Chorioamniotic Membranes (Biol Reprod 2016) - IL-1 Receptor Blockade Prevents Fetal Cortical Brain Injury But Not Preterm Birth - Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques - Airway inflammatory cell responses to intra-amniotic LPS in a sheep model of chorioamnionitis - Inflammation in fetal sheep from intra-amniotic injection of Ureaplasma parvum - TLR4 antagonist inhibits LPS-induced preterm uterine contractility in rhesus monkeys - Ureaplasma diversum lipoproteins activate inflammatory genes through NF-κB via TLR4 - Acute Histologic Chorioamnionitis at Term: Nearly Always Noninfectious - Polymorphisms in immunoregulatory genes and risk of histologic chorioamnionitis - Chorioamnionitis and Neonatal Outcomes (review) - Chorioamnionitis and Patent Ductus Arteriosus: systematic review and meta-analysis - Azithromycin vs erythromycin in PPROM: lower chorioamnionitis and endometritis - A population-based study of the risk of repeat clinical chorioamnionitis, Washington State 1989–2008 - Transcriptomic analysis of equine chorioallantois in nocardioform placentitis (Vet Res 2021) - Fusobacterium nucleatum Induces Premature and Term Stillbirths in Pregnant Mice (Infect Immun 2004) - Characterization of an Adapted Murine Model of Intrauterine Inflammation–Induced Preterm Birth (Am J Pathol 2019) - Proteomic Profiling of the Amniotic Fluid to Detect Inflammation, Infection, and Neonatal Sepsis (PLOS Med 2007) - Advances in Medical Diagnosis of Intra-Amniotic Infection
Guidelines, ontologies and reference resources: - ACOG — Intrapartum Management of Intraamniotic Infection (Committee Opinion 712) - ACOG — Prevention of Group B Streptococcal Early-Onset Disease in Newborns (2020) - AAP — Management of Infants at Risk for Group B Streptococcal Disease (Pediatrics 2019) - CDC — Clinical Overview of Group B Strep Disease - StatPearls — Chorioamnionitis (NCBI Bookshelf NBK532251) - Merck Manual Professional — Intraamniotic Infection (Chorioamnionitis) - Mondo Disease Ontology — Monarch Initiative - ICD-10-CM O41.12 Chorioamnionitis - Kaiser Permanente — Rate of Chorioamnionitis More than Doubled since 1995 - Frontiers in Medicine 2023 — Clinical chorioamnionitis: where do we stand now? - Intrauterine inflammation, infection, or both (Triple I): A new concept for chorioamnionitis (Pediatr Neonatol 2017)